ONTOLOGY REPORT - ANNOTATIONS
| Term: | silicon dioxide |
|
| Accession: | CHEBI:30563
|
browse the term
|
| Definition: | A silicon oxide made up of linear triatomic molecules in which a silicon atom is covalently bonded to two oxygens. |
| Synonyms: | exact_synonym: | silicon(IV) oxide |
| | related_synonym: | (SiO2)n; InChI=1S/O2Si/c1-3-2; InChIKey=VYPSYNLAJGMNEJ-UHFFFAOYSA-N; Kieselsaeureanhydrid; O2Si; O=[Si]=O; SiO2; Siliziumdioxid; silica; silicic anhydride |
| | xref_casrn: | 7631-86-9 |
| | xref: | ChemIDplus:7631-86-9 "CAS Registry Number"; CiteXplore:8991630 "PubMed citation"; Gmelin:200274 "Gmelin Registry Number" |
| | xref_mesh: | MESH:D012822 |
| | xref: | MolBase:887 "MolBase"; NIST Chemistry WebBook:7631-86-9 "CAS Registry Number"; Reaxys:3902804 "Reaxys Registry Number" |
|
|
silicon dioxide
|
| G |
ABCA1 |
ATP-binding cassette, sub-family A (ABC1), member 1 |
|
decreases expression |
ISO |
9 |
107,543,283 |
107,690,527 |
RGD:6480464 |
CTD |
| G |
ABCD2 |
ATP-binding cassette, sub-family D (ALD), member 2 |
|
decreases expression |
ISO |
12 |
39,945,022 |
40,013,843 |
RGD:6480464 |
CTD |
| G |
ABHD6 |
abhydrolase domain containing 6 |
|
decreases expression |
ISO |
3 |
58,223,259 |
58,280,461 |
RGD:6480464 |
CTD |
| G |
ACLY |
ATP citrate lyase |
|
increases activity |
ISO |
17 |
40,023,179 |
40,075,272 |
RGD:6480464 |
CTD |
| G |
ADRB2 |
adrenoceptor beta 2, surface |
|
decreases expression |
ISO |
5 |
148,206,156 |
148,208,197 |
RGD:6480464 |
CTD |
| G |
AFF1 |
AF4/FMR2 family, member 1 |
|
increases expression |
ISO |
4 |
87,856,154 |
88,062,206 |
RGD:6480464 |
CTD |
| G |
AGFG2 |
ArfGAP with FG repeats 2 |
|
decreases expression |
ISO |
7 |
100,136,834 |
100,165,843 |
RGD:6480464 |
CTD |
| G |
AHCYL2 |
adenosylhomocysteinase-like 2 |
|
increases expression |
ISO |
7 |
128,864,855 |
129,070,052 |
RGD:6480464 |
CTD |
| G |
AHR |
aryl hydrocarbon receptor |
|
affects response to substance |
ISO |
7 |
17,338,276 |
17,385,775 |
RGD:6480464 |
CTD |
| G |
AHR |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
7 |
17,338,276 |
17,385,775 |
RGD:6480464 |
CTD |
| G |
AKNA |
AT-hook transcription factor |
|
decreases expression |
ISO |
9 |
117,096,429 |
117,156,685 |
RGD:6480464 |
CTD |
| G |
AKR1B10 |
aldo-keto reductase family 1, member B10 (aldose reductase) |
|
decreases expression |
ISO |
7 |
134,212,344 |
134,226,166 |
RGD:6480464 |
CTD |
| G |
AKTIP |
AKT interacting protein |
|
decreases expression |
ISO |
16 |
53,525,192 |
53,537,170 |
RGD:6480464 |
CTD |
| G |
ALKBH4 |
alkB, alkylation repair homolog 4 (E. coli) |
|
decreases expression |
ISO |
7 |
102,096,667 |
102,105,321 |
RGD:6480464 |
CTD |
| G |
ALOX5 |
arachidonate 5-lipoxygenase |
|
increases expression |
ISO |
10 |
45,869,624 |
45,941,567 |
RGD:6480464 |
CTD |
| G |
ALOX5AP |
arachidonate 5-lipoxygenase-activating protein |
|
increases expression |
ISO |
13 |
31,287,615 |
31,338,565 |
RGD:6480464 |
CTD |
| G |
AMPD3 |
adenosine monophosphate deaminase 3 |
|
decreases expression |
ISO |
11 |
10,471,868 |
10,529,126 |
RGD:6480464 |
CTD |
| G |
ANGPTL4 |
angiopoietin-like 4 |
|
decreases expression |
ISO |
19 |
8,429,011 |
8,439,257 |
RGD:6480464 |
CTD |
| G |
ANKRD10 |
ankyrin repeat domain 10 |
|
decreases expression |
ISO |
13 |
111,530,887 |
111,567,416 |
RGD:6480464 |
CTD |
| G |
ANKRD49 |
ankyrin repeat domain 49 |
|
decreases expression |
ISO |
11 |
94,227,153 |
94,232,744 |
RGD:6480464 |
CTD |
| G |
AP2A2 |
adaptor-related protein complex 2, alpha 2 subunit |
|
decreases expression |
ISO |
11 |
925,809 |
1,012,245 |
RGD:6480464 |
CTD |
| G |
AQP1 |
aquaporin 1 (Colton blood group) |
|
increases expression |
ISO |
7 |
30,951,415 |
30,965,131 |
RGD:6480464 |
CTD |
| G |
AQR |
aquarius homolog (mouse) |
|
decreases expression |
ISO |
15 |
35,148,552 |
35,261,995 |
RGD:6480464 |
CTD |
| G |
ARC |
activity-regulated cytoskeleton-associated protein |
|
increases expression |
ISO |
8 |
143,692,405 |
143,695,833 |
RGD:6480464 |
CTD |
| G |
AREG |
amphiregulin |
|
increases expression |
ISO |
4 |
75,310,853 |
75,320,726 |
RGD:6480464 |
CTD |
| G |
ARHGAP39 |
Rho GTPase activating protein 39 |
|
decreases expression |
ISO |
8 |
145,754,563 |
145,838,891 |
RGD:6480464 |
CTD |
| G |
ARHGAP5 |
Rho GTPase activating protein 5 |
|
decreases expression |
ISO |
14 |
32,546,495 |
32,628,934 |
RGD:6480464 |
CTD |
| G |
ARHGEF10 |
Rho guanine nucleotide exchange factor (GEF) 10 |
|
decreases expression |
ISO |
8 |
1,772,149 |
1,906,807 |
RGD:6480464 |
CTD |
| G |
ARHGEF3 |
Rho guanine nucleotide exchange factor (GEF) 3 |
|
decreases expression |
ISO |
3 |
56,761,446 |
57,113,336 |
RGD:6480464 |
CTD |
| G |
ARID5A |
AT rich interactive domain 5A (MRF1-like) |
|
increases expression |
ISO |
2 |
97,202,464 |
97,218,371 |
RGD:6480464 |
CTD |
| G |
ARPP19 |
cAMP-regulated phosphoprotein, 19kDa |
|
decreases expression |
ISO |
15 |
52,839,432 |
52,861,213 |
RGD:6480464 |
CTD |
| G |
ASB13 |
ankyrin repeat and SOCS box containing 13 |
|
decreases expression |
ISO |
10 |
5,680,820 |
5,708,558 |
RGD:6480464 |
CTD |
| G |
ASPH |
aspartate beta-hydroxylase |
|
decreases expression |
ISO |
8 |
62,413,115 |
62,627,199 |
RGD:6480464 |
CTD |
| G |
ASPH |
aspartate beta-hydroxylase |
|
increases expression |
ISO |
8 |
62,413,115 |
62,627,199 |
RGD:6480464 |
CTD |
| G |
ASPH |
aspartate beta-hydroxylase |
|
decreases expression |
ISO |
8 |
62,413,115 |
62,627,199 |
RGD:6480464 |
CTD |
| G |
ASPH |
aspartate beta-hydroxylase |
|
increases expression |
ISO |
8 |
62,413,115 |
62,627,199 |
RGD:6480464 |
CTD |
| G |
ASPM |
asp (abnormal spindle) homolog, microcephaly associated (Drosophila) |
|
decreases expression |
ISO |
1 |
197,053,257 |
197,115,824 |
RGD:6480464 |
CTD |
| G |
ATF3 |
activating transcription factor 3 |
|
increases expression |
ISO |
1 |
212,738,676 |
212,794,119 |
RGD:6480464 |
CTD |
| G |
ATM |
ataxia telangiectasia mutated |
|
decreases expression |
ISO |
11 |
108,093,559 |
108,239,826 |
RGD:6480464 |
CTD |
| G |
ATP11A |
ATPase, class VI, type 11A |
|
decreases expression |
ISO |
13 |
113,344,643 |
113,541,482 |
RGD:6480464 |
CTD |
| G |
ATP5C1 |
ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1 |
|
decreases expression |
ISO |
10 |
7,830,093 |
7,849,764 |
RGD:6480464 |
CTD |
| G |
ATP5G2 |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9) |
|
decreases expression |
ISO |
12 |
54,058,944 |
54,070,512 |
RGD:6480464 |
CTD |
| G |
ATRX |
alpha thalassemia/mental retardation syndrome X-linked |
|
increases expression |
ISO |
X |
76,760,356 |
77,041,719 |
RGD:6480464 |
CTD |
| G |
B2M |
beta-2-microglobulin |
|
decreases expression |
ISO |
15 |
45,003,685 |
45,010,357 |
RGD:6480464 |
CTD |
| G |
B3GALNT2 |
beta-1,3-N-acetylgalactosaminyltransferase 2 |
|
decreases expression |
ISO |
1 |
235,610,533 |
235,667,781 |
RGD:6480464 |
CTD |
| G |
B4GALT6 |
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 6 |
|
decreases expression |
ISO |
18 |
29,202,209 |
29,264,686 |
RGD:6480464 |
CTD |
| G |
BAX |
BCL2-associated X protein |
|
increases expression |
EXP |
19 |
49,458,117 |
49,465,055 |
RGD:6480464 |
CTD |
| G |
BAX |
BCL2-associated X protein |
|
multiple interactions |
EXP |
19 |
49,458,117 |
49,465,055 |
RGD:6480464 |
CTD |
| G |
BAX |
BCL2-associated X protein |
|
increases expression |
EXP |
19 |
49,458,117 |
49,465,055 |
RGD:6480464 |
CTD |
| G |
BAX |
BCL2-associated X protein |
|
increases expression |
EXP |
19 |
49,458,117 |
49,465,055 |
RGD:6480464 |
CTD |
| G |
BBC3 |
BCL2 binding component 3 |
|
increases expression |
ISO |
19 |
47,724,079 |
47,736,023 |
RGD:6480464 |
CTD |
| G |
BCAR3 |
breast cancer anti-estrogen resistance 3 |
|
increases expression |
ISO |
1 |
94,027,343 |
94,312,706 |
RGD:6480464 |
CTD |
| G |
BCL10 |
B-cell CLL/lymphoma 10 |
|
increases expression |
ISO |
1 |
85,731,459 |
85,742,587 |
RGD:6480464 |
CTD |
| G |
BCL2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
18 |
60,790,579 |
60,986,613 |
RGD:6480464 |
CTD |
| G |
BCL2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
EXP |
18 |
60,790,579 |
60,986,613 |
RGD:6480464 |
CTD |
| G |
BCL2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
18 |
60,790,579 |
60,986,613 |
RGD:6480464 |
CTD |
| G |
BCL2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
EXP |
18 |
60,790,579 |
60,986,613 |
RGD:6480464 |
CTD |
| G |
BCL2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
EXP |
18 |
60,790,579 |
60,986,613 |
RGD:6480464 |
CTD |
| G |
BCL2A1 |
BCL2-related protein A1 |
|
increases expression |
EXP |
15 |
80,253,232 |
80,263,643 |
RGD:6480464 |
CTD |
| G |
BCL2L11 |
BCL2-like 11 (apoptosis facilitator) |
|
increases expression |
ISO |
2 |
111,878,491 |
111,926,022 |
RGD:6480464 |
CTD |
| G |
BCL6 |
B-cell CLL/lymphoma 6 |
|
decreases expression |
ISO |
3 |
187,439,165 |
187,463,513 |
RGD:6480464 |
CTD |
| G |
BIRC6 |
baculoviral IAP repeat containing 6 |
|
increases expression |
ISO |
2 |
32,582,096 |
32,843,966 |
RGD:6480464 |
CTD |
| G |
BMP2 |
bone morphogenetic protein 2 |
|
increases expression |
EXP |
20 |
6,748,745 |
6,760,910 |
RGD:6480464 |
CTD |
| G |
BRD2 |
bromodomain containing 2 |
|
increases expression |
ISO |
6 |
32,936,437 |
32,949,282 |
RGD:6480464 |
CTD |
| G |
BRD8 |
bromodomain containing 8 |
|
decreases expression |
ISO |
5 |
137,475,459 |
137,514,358 |
RGD:6480464 |
CTD |
| G |
BST1 |
bone marrow stromal cell antigen 1 |
|
increases expression |
ISO |
4 |
15,704,573 |
15,733,796 |
RGD:6480464 |
CTD |
| G |
BTG2 |
BTG family, member 2 |
|
increases expression |
ISO |
1 |
203,274,664 |
203,278,730 |
RGD:6480464 |
CTD |
| G |
BTG3 |
BTG family, member 3 |
|
increases expression |
ISO |
21 |
18,965,968 |
18,985,268 |
RGD:6480464 |
CTD |
| G |
BZW2 |
basic leucine zipper and W2 domains 2 |
|
increases expression |
ISO |
7 |
16,685,759 |
16,746,148 |
RGD:6480464 |
CTD |
| G |
C1D |
C1D nuclear receptor corepressor |
|
decreases expression |
ISO |
2 |
68,269,332 |
68,290,159 |
RGD:6480464 |
CTD |
| G |
C1R |
complement component 1, r subcomponent |
|
decreases expression |
ISO |
12 12 |
7,241,205 7,187,513 |
7,245,043 7,189,412 |
RGD:6480464 |
CTD |
| G |
C21orf91 |
chromosome 21 open reading frame 91 |
|
decreases expression |
ISO |
21 |
19,161,284 |
19,191,703 |
RGD:6480464 |
CTD |
| G |
C2orf42 |
chromosome 2 open reading frame 42 |
|
decreases expression |
ISO |
2 |
70,377,017 |
70,418,151 |
RGD:6480464 |
CTD |
| G |
C3AR1 |
complement component 3a receptor 1 |
|
increases expression |
ISO |
12 |
8,210,919 |
8,218,955 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
decreases expression |
ISO |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCRL |
calcitonin receptor-like |
|
decreases expression |
ISO |
2 |
188,207,846 |
188,313,021 |
RGD:6480464 |
CTD |
| G |
CALHM2 |
calcium homeostasis modulator 2 |
|
decreases expression |
ISO |
10 |
105,206,543 |
105,212,162 |
RGD:6480464 |
CTD |
| G |
CAPN7 |
calpain 7 |
|
decreases expression |
ISO |
3 |
15,247,733 |
15,294,423 |
RGD:6480464 |
CTD |
| G |
CASP1 |
caspase 1, apoptosis-related cysteine peptidase |
|
increases expression |
ISO |
11 |
104,896,235 |
104,905,884 |
RGD:6480464 |
CTD |
| G |
CASP1 |
caspase 1, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
11 |
104,896,235 |
104,905,884 |
RGD:6480464 |
CTD |
| G |
CASP1 |
caspase 1, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
11 |
104,896,235 |
104,905,884 |
RGD:6480464 |
CTD |
| G |
CASP1 |
caspase 1, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
11 |
104,896,235 |
104,905,884 |
RGD:6480464 |
CTD |
| G |
CASP2 |
caspase 2, apoptosis-related cysteine peptidase |
|
decreases expression |
ISO |
7 |
142,985,308 |
143,004,789 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
increases expression |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
increases activity |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
increases expression |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
increases activity |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
increases expression |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP8AP2 |
caspase 8 associated protein 2 |
|
decreases expression |
ISO |
6 |
90,539,619 |
90,584,155 |
RGD:6480464 |
CTD |
| G |
CAT |
catalase |
|
decreases expression |
ISO |
11 |
34,460,472 |
34,493,607 |
RGD:6480464 |
CTD |
| G |
CAT |
catalase |
|
increases expression |
EXP |
11 |
34,460,472 |
34,493,607 |
RGD:6480464 |
CTD |
| G |
CBX4 |
chromobox homolog 4 |
|
decreases expression |
ISO |
17 |
77,806,955 |
77,813,213 |
RGD:6480464 |
CTD |
| G |
CBX6 |
chromobox homolog 6 |
|
decreases expression |
ISO |
22 |
39,260,243 |
39,268,258 |
RGD:6480464 |
CTD |
| G |
CBX8 |
chromobox homolog 8 |
|
decreases expression |
ISO |
17 |
77,768,176 |
77,770,915 |
RGD:6480464 |
CTD |
| G |
CCDC117 |
coiled-coil domain containing 117 |
|
decreases expression |
ISO |
22 |
29,168,662 |
29,185,283 |
RGD:6480464 |
CTD |
| G |
CCDC39 |
coiled-coil domain containing 39 |
|
decreases expression |
ISO |
3 |
180,331,796 |
180,397,283 |
RGD:6480464 |
CTD |
| G |
CCL17 |
chemokine (C-C motif) ligand 17 |
|
increases expression |
ISO |
16 |
57,438,679 |
57,449,974 |
RGD:6480464 |
CTD |
| G |
CCL17 |
chemokine (C-C motif) ligand 17 |
|
decreases expression |
EXP |
16 |
57,438,679 |
57,449,974 |
RGD:6480464 |
CTD |
| G |
CCL19 |
chemokine (C-C motif) ligand 19 |
|
decreases expression |
EXP |
9 |
34,689,567 |
34,691,274 |
RGD:6480464 |
CTD |
| G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
ISO |
17 |
32,582,296 |
32,584,222 |
RGD:6480464 |
CTD |
| G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
ISO |
17 |
32,582,296 |
32,584,222 |
RGD:6480464 |
CTD |
| G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
17 |
32,582,296 |
32,584,222 |
RGD:6480464 |
CTD |
| G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
increases secretion |
ISO |
17 |
32,582,296 |
32,584,222 |
RGD:6480464 |
CTD |
| G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
17 |
32,582,296 |
32,584,222 |
RGD:6480464 |
CTD |
| G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
17 |
32,582,296 |
32,584,222 |
RGD:6480464 |
CTD |
| G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
17 |
32,582,296 |
32,584,222 |
RGD:6480464 |
CTD |
| G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
ISO |
17 |
32,582,296 |
32,584,222 |
RGD:6480464 |
CTD |
| G |
CCL20 |
chemokine (C-C motif) ligand 20 |
|
increases expression |
EXP |
2 |
228,678,558 |
228,682,280 |
RGD:6480464 |
CTD |
| G |
CCL20 |
chemokine (C-C motif) ligand 20 |
|
increases expression |
EXP |
2 |
228,678,558 |
228,682,280 |
RGD:6480464 |
CTD |
| G |
CCL21 |
chemokine (C-C motif) ligand 21 |
|
decreases expression |
EXP |
9 |
34,709,002 |
34,710,147 |
RGD:6480464 |
CTD |
| G |
CCL24 |
chemokine (C-C motif) ligand 24 |
|
decreases expression |
EXP |
7 |
75,441,114 |
75,443,033 |
RGD:6480464 |
CTD |
| G |
CCL3 |
chemokine (C-C motif) ligand 3 |
|
increases expression |
ISO |
17 |
34,415,602 |
34,417,506 |
RGD:6480464 |
CTD |
| G |
CCL4 |
chemokine (C-C motif) ligand 4 |
|
increases expression |
ISO |
17 |
34,431,220 |
34,433,014 |
RGD:6480464 |
CTD |
| G |
CCL5 |
chemokine (C-C motif) ligand 5 |
|
increases secretion |
ISO |
17 |
34,198,495 |
34,207,377 |
RGD:6480464 |
CTD |
| G |
CCL5 |
chemokine (C-C motif) ligand 5 |
|
multiple interactions |
ISO |
17 |
34,198,495 |
34,207,377 |
RGD:6480464 |
CTD |
| G |
CCL7 |
chemokine (C-C motif) ligand 7 |
|
multiple interactions |
ISO |
17 |
32,597,240 |
32,599,256 |
RGD:6480464 |
CTD |
| G |
CCNE2 |
cyclin E2 |
|
decreases expression |
ISO |
8 |
95,892,452 |
95,907,482 |
RGD:6480464 |
CTD |
| G |
CCNJ |
cyclin J |
|
decreases expression |
ISO |
10 |
97,803,159 |
97,820,627 |
RGD:6480464 |
CTD |
| G |
CCNL1 |
cyclin L1 |
|
increases expression |
ISO |
3 |
156,865,585 |
156,878,482 |
RGD:6480464 |
CTD |
| G |
CCNT2 |
cyclin T2 |
|
decreases expression |
ISO |
2 |
135,676,392 |
135,716,915 |
RGD:6480464 |
CTD |
| G |
CCPG1 |
cell cycle progression 1 |
|
decreases expression |
ISO |
15 |
55,647,421 |
55,700,708 |
RGD:6480464 |
CTD |
| G |
CCR1 |
chemokine (C-C motif) receptor 1 |
|
increases expression |
ISO |
3 |
46,243,200 |
46,249,832 |
RGD:6480464 |
CTD |
| G |
CCR2 |
chemokine (C-C motif) receptor 2 |
|
increases expression |
ISO |
3 |
46,395,235 |
46,402,413 |
RGD:6480464 |
CTD |
| G |
CCR6 |
chemokine (C-C motif) receptor 6 |
|
decreases expression |
EXP |
6 |
167,525,295 |
167,552,629 |
RGD:6480464 |
CTD |
| G |
CCR7 |
chemokine (C-C motif) receptor 7 |
|
decreases expression |
EXP |
17 |
38,710,021 |
38,721,736 |
RGD:6480464 |
CTD |
| G |
CCR8 |
chemokine (C-C motif) receptor 8 |
|
decreases expression |
EXP |
3 |
39,371,197 |
39,375,171 |
RGD:6480464 |
CTD |
| G |
CCRL2 |
chemokine (C-C motif) receptor-like 2 |
|
increases expression |
ISO |
3 |
46,448,721 |
46,451,014 |
RGD:6480464 |
CTD |
| G |
CD200R1 |
CD200 receptor 1 |
|
decreases expression |
ISO |
3 |
112,641,532 |
112,693,937 |
RGD:6480464 |
CTD |
| G |
CD37 |
CD37 molecule |
|
decreases expression |
ISO |
19 |
49,838,677 |
49,843,863 |
RGD:6480464 |
CTD |
| G |
CD44 |
CD44 molecule (Indian blood group) |
|
increases expression |
ISO |
11 |
35,160,417 |
35,253,949 |
RGD:6480464 |
CTD |
| G |
CD44 |
CD44 molecule (Indian blood group) |
|
increases expression |
ISO |
11 |
35,160,417 |
35,253,949 |
RGD:6480464 |
CTD |
| G |
CD83 |
CD83 molecule |
|
increases expression |
ISO |
6 |
14,117,487 |
14,137,149 |
RGD:6480464 |
CTD |
| G |
CD86 |
CD86 molecule |
|
increases expression |
ISO |
3 |
121,774,209 |
121,839,990 |
RGD:6480464 |
CTD |
| G |
CD97 |
CD97 molecule |
|
increases expression |
ISO |
19 |
14,491,956 |
14,519,537 |
RGD:6480464 |
CTD |
| G |
CDC37L1 |
cell division cycle 37-like 1 |
|
decreases expression |
ISO |
9 |
4,679,566 |
4,706,594 |
RGD:6480464 |
CTD |
| G |
CDK12 |
cyclin-dependent kinase 12 |
|
increases expression |
ISO |
17 |
37,617,739 |
37,690,800 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
increases expression |
ISO |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CEBPB |
CCAAT/enhancer binding protein (C/EBP), beta |
|
increases expression |
ISO |
20 |
48,807,120 |
48,809,227 |
RGD:6480464 |
CTD |
| G |
CEBPB |
CCAAT/enhancer binding protein (C/EBP), beta |
|
increases expression |
EXP |
20 |
48,807,120 |
48,809,227 |
RGD:6480464 |
CTD |
| G |
CEP68 |
centrosomal protein 68kDa |
|
decreases expression |
ISO |
2 |
65,283,495 |
65,314,142 |
RGD:6480464 |
CTD |
| G |
CFH |
complement factor H |
|
decreases expression |
ISO |
1 |
196,621,008 |
196,716,634 |
RGD:6480464 |
CTD |
| G |
CFL2 |
cofilin 2 (muscle) |
|
decreases expression |
ISO |
14 |
35,179,588 |
35,184,029 |
RGD:6480464 |
CTD |
| G |
CFLAR |
CASP8 and FADD-like apoptosis regulator |
|
increases expression |
ISO |
2 |
201,980,877 |
202,037,411 |
RGD:6480464 |
CTD |
| G |
CHAC1 |
ChaC, cation transport regulator homolog 1 (E. coli) |
|
increases expression |
ISO |
15 |
41,245,636 |
41,248,717 |
RGD:6480464 |
CTD |
| G |
CHKA |
choline kinase alpha |
|
increases expression |
ISO |
11 |
67,820,326 |
67,888,858 |
RGD:6480464 |
CTD |
| G |
CHPT1 |
choline phosphotransferase 1 |
|
decreases expression |
ISO |
12 |
102,091,417 |
102,122,846 |
RGD:6480464 |
CTD |
| G |
CHST1 |
carbohydrate (keratan sulfate Gal-6) sulfotransferase 1 |
|
decreases expression |
ISO |
11 |
45,669,239 |
45,687,206 |
RGD:6480464 |
CTD |
| G |
CHST12 |
carbohydrate (chondroitin 4) sulfotransferase 12 |
|
decreases expression |
ISO |
7 |
2,443,195 |
2,474,242 |
RGD:6480464 |
CTD |
| G |
CKLF |
chemokine-like factor |
|
decreases expression |
ISO |
16 |
66,586,466 |
66,600,190 |
RGD:6480464 |
CTD |
| G |
CLCC1 |
chloride channel CLIC-like 1 |
|
decreases expression |
ISO |
1 |
109,472,130 |
109,506,111 |
RGD:6480464 |
CTD |
| G |
CLEC4D |
C-type lectin domain family 4, member D |
|
increases expression |
ISO |
12 |
8,666,136 |
8,674,962 |
RGD:6480464 |
CTD |
| G |
CLEC4E |
C-type lectin domain family 4, member E |
|
increases expression |
ISO |
12 |
8,685,901 |
8,693,558 |
RGD:6480464 |
CTD |
| G |
CLEC4E |
C-type lectin domain family 4, member E |
|
increases expression |
ISO |
12 |
8,685,901 |
8,693,558 |
RGD:6480464 |
CTD |
| G |
CLK4 |
CDC-like kinase 4 |
|
increases expression |
ISO |
5 |
178,029,665 |
178,054,054 |
RGD:6480464 |
CTD |
| G |
CMPK2 |
cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial |
|
decreases expression |
ISO |
2 |
6,980,684 |
7,006,766 |
RGD:6480464 |
CTD |
| G |
CNNM3 |
cyclin M3 |
|
decreases expression |
ISO |
2 |
97,481,991 |
97,501,121 |
RGD:6480464 |
CTD |
| G |
CNR2 |
cannabinoid receptor 2 (macrophage) |
|
decreases expression |
ISO |
1 |
24,200,460 |
24,239,817 |
RGD:6480464 |
CTD |
| G |
COL4A5 |
collagen, type IV, alpha 5 |
|
decreases expression |
ISO |
X |
107,683,074 |
107,940,775 |
RGD:6480464 |
CTD |
| G |
CORO1A |
coronin, actin binding protein, 1A |
|
decreases expression |
ISO |
16 |
30,194,731 |
30,200,397 |
RGD:6480464 |
CTD |
| G |
COX7C |
cytochrome c oxidase subunit VIIc |
|
decreases expression |
ISO |
5 |
85,913,784 |
85,916,583 |
RGD:6480464 |
CTD |
| G |
CP |
ceruloplasmin (ferroxidase) |
|
decreases expression |
ISO |
3 |
148,880,197 |
148,939,832 |
RGD:6480464 |
CTD |
| G |
CPEB4 |
cytoplasmic polyadenylation element binding protein 4 |
|
increases expression |
ISO |
5 |
173,315,331 |
173,387,313 |
RGD:6480464 |
CTD |
| G |
CREM |
cAMP responsive element modulator |
|
increases expression |
ISO |
10 |
35,415,769 |
35,501,886 |
RGD:6480464 |
CTD |
| G |
CROT |
carnitine O-octanoyltransferase |
|
decreases expression |
ISO |
7 |
86,974,951 |
87,029,112 |
RGD:6480464 |
CTD |
| G |
CSF1 |
colony stimulating factor 1 (macrophage) |
|
increases expression |
ISO |
1 |
110,453,233 |
110,473,616 |
RGD:6480464 |
CTD |
| G |
CSF2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
increases expression |
EXP |
5 |
131,409,485 |
131,411,863 |
RGD:6480464 |
CTD |
| G |
CSF2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
multiple interactions |
ISO |
5 |
131,409,485 |
131,411,863 |
RGD:6480464 |
CTD |
| G |
CSF2RB |
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) |
|
decreases expression |
ISO |
22 |
37,309,675 |
37,336,481 |
RGD:6480464 |
CTD |
| G |
CSF3 |
colony stimulating factor 3 (granulocyte) |
|
increases secretion |
ISO |
17 |
38,171,614 |
38,174,066 |
RGD:6480464 |
CTD |
| G |
CSF3 |
colony stimulating factor 3 (granulocyte) |
|
multiple interactions |
ISO |
17 |
38,171,614 |
38,174,066 |
RGD:6480464 |
CTD |
| G |
CTR9 |
Ctr9, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae) |
|
decreases expression |
ISO |
11 |
10,772,811 |
10,801,290 |
RGD:6480464 |
CTD |
| G |
CTSB |
cathepsin B |
|
multiple interactions |
ISO |
8 |
11,700,033 |
11,725,646 |
RGD:6480464 |
CTD |
| G |
CTTNBP2NL |
CTTNBP2 N-terminal like |
|
increases expression |
ISO |
1 |
112,938,800 |
113,003,786 |
RGD:6480464 |
CTD |
| G |
CTU1 |
cytosolic thiouridylase subunit 1 |
|
decreases expression |
ISO |
19 |
51,600,863 |
51,611,647 |
RGD:6480464 |
CTD |
| G |
CUL2 |
cullin 2 |
|
decreases expression |
ISO |
10 |
35,297,479 |
35,379,570 |
RGD:6480464 |
CTD |
| G |
CUL3 |
cullin 3 |
|
decreases expression |
ISO |
2 |
225,334,867 |
225,450,114 |
RGD:6480464 |
CTD |
| G |
CX3CR1 |
chemokine (C-X3-C motif) receptor 1 |
|
decreases expression |
ISO |
3 |
39,304,985 |
39,323,226 |
RGD:6480464 |
CTD |
| G |
CXCL1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
ISO |
4 |
74,735,109 |
74,737,019 |
RGD:6480464 |
CTD |
| G |
CXCL1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
increases expression |
EXP |
4 |
74,735,109 |
74,737,019 |
RGD:6480464 |
CTD |
| G |
CXCL1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
ISO |
4 |
74,735,109 |
74,737,019 |
RGD:6480464 |
CTD |
| G |
CXCL1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
ISO |
4 |
74,735,109 |
74,737,019 |
RGD:6480464 |
CTD |
| G |
CXCL1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
increases secretion |
ISO |
4 |
74,735,109 |
74,737,019 |
RGD:6480464 |
CTD |
| G |
CXCL1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
increases expression |
ISO |
4 |
74,735,109 |
74,737,019 |
RGD:6480464 |
CTD |
| G |
CXCL1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
ISO |
4 |
74,735,109 |
74,737,019 |
RGD:6480464 |
CTD |
| G |
CXCL1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
ISO |
4 |
74,735,109 |
74,737,019 |
RGD:6480464 |
CTD |
| G |
CXCL1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
increases expression |
ISO |
4 |
74,735,109 |
74,737,019 |
RGD:6480464 |
CTD |
| G |
CXCL10 |
chemokine (C-X-C motif) ligand 10 |
|
increases expression |
ISO |
4 |
76,942,269 |
76,944,689 |
RGD:6480464 |
CTD |
| G |
CXCL10 |
chemokine (C-X-C motif) ligand 10 |
|
increases expression |
EXP |
4 |
76,942,269 |
76,944,689 |
RGD:6480464 |
CTD |
| G |
CXCL10 |
chemokine (C-X-C motif) ligand 10 |
|
multiple interactions |
ISO |
4 |
76,942,269 |
76,944,689 |
RGD:6480464 |
CTD |
| G |
CXCL11 |
chemokine (C-X-C motif) ligand 11 |
|
increases expression |
EXP |
4 |
76,954,835 |
76,957,350 |
RGD:6480464 |
CTD |
| G |
CXCL13 |
chemokine (C-X-C motif) ligand 13 |
|
decreases expression |
EXP |
4 |
78,432,907 |
78,532,988 |
RGD:6480464 |
CTD |
| G |
CXCL2 |
chemokine (C-X-C motif) ligand 2 |
|
increases expression |
ISO |
4 |
74,962,752 |
74,964,997 |
RGD:6480464 |
CTD |
| G |
CXCL2 |
chemokine (C-X-C motif) ligand 2 |
|
increases expression |
ISO |
4 |
74,962,752 |
74,964,997 |
RGD:6480464 |
CTD |
| G |
CXCL2 |
chemokine (C-X-C motif) ligand 2 |
|
multiple interactions |
ISO |
4 |
74,962,752 |
74,964,997 |
RGD:6480464 |
CTD |
| G |
CXCL2 |
chemokine (C-X-C motif) ligand 2 |
|
multiple interactions |
ISO |
4 |
74,962,752 |
74,964,997 |
RGD:6480464 |
CTD |
| G |
CXCL2 |
chemokine (C-X-C motif) ligand 2 |
|
increases expression |
ISO |
4 |
74,962,752 |
74,964,997 |
RGD:6480464 |
CTD |
| G |
CXCL2 |
chemokine (C-X-C motif) ligand 2 |
|
multiple interactions |
ISO |
4 |
74,962,752 |
74,964,997 |
RGD:6480464 |
CTD |
| G |
CXCL3 |
chemokine (C-X-C motif) ligand 3 |
|
increases expression |
EXP |
4 |
74,902,306 |
74,904,490 |
RGD:6480464 |
CTD |
| G |
CXCL5 |
chemokine (C-X-C motif) ligand 5 |
|
increases expression |
EXP |
4 |
74,861,359 |
74,864,416 |
RGD:6480464 |
CTD |
| G |
CXCL9 |
chemokine (C-X-C motif) ligand 9 |
|
increases expression |
EXP |
4 |
76,922,623 |
76,928,641 |
RGD:6480464 |
CTD |
| G |
CXCR2 |
chemokine (C-X-C motif) receptor 2 |
|
increases expression |
ISO |
2 |
218,990,013 |
219,001,976 |
RGD:6480464 |
CTD |
| G |
CXCR2 |
chemokine (C-X-C motif) receptor 2 |
|
decreases expression |
EXP |
2 |
218,990,013 |
219,001,976 |
RGD:6480464 |
CTD |
| G |
CXCR4 |
chemokine (C-X-C motif) receptor 4 |
|
increases expression |
ISO |
2 |
136,871,919 |
136,875,725 |
RGD:6480464 |
CTD |
| G |
CXXC5 |
CXXC finger protein 5 |
|
decreases expression |
ISO |
5 |
139,028,301 |
139,062,680 |
RGD:6480464 |
CTD |
| G |
CYBA |
cytochrome b-245, alpha polypeptide |
|
increases expression |
ISO |
16 |
88,709,697 |
88,717,492 |
RGD:6480464 |
CTD |
| G |
CYSLTR1 |
cysteinyl leukotriene receptor 1 |
|
decreases expression |
ISO |
X |
77,528,130 |
77,583,087 |
RGD:6480464 |
CTD |
| G |
CYTIP |
cytohesin 1 interacting protein |
|
decreases expression |
ISO |
2 |
158,271,131 |
158,300,604 |
RGD:6480464 |
CTD |
| G |
DAGLB |
diacylglycerol lipase, beta |
|
decreases expression |
ISO |
7 |
6,448,747 |
6,487,643 |
RGD:6480464 |
CTD |
| G |
DAPP1 |
dual adaptor of phosphotyrosine and 3-phosphoinositides |
|
decreases expression |
ISO |
4 |
100,737,981 |
100,791,347 |
RGD:6480464 |
CTD |
| G |
DCUN1D1 |
DCN1, defective in cullin neddylation 1, domain containing 1 (S. cerevisiae) |
|
decreases expression |
ISO |
3 |
182,660,559 |
182,698,326 |
RGD:6480464 |
CTD |
| G |
DDIT3 |
DNA-damage-inducible transcript 3 |
|
increases expression |
ISO |
12 |
57,910,371 |
57,914,300 |
RGD:6480464 |
CTD |
| G |
DDIT4 |
DNA-damage-inducible transcript 4 |
|
increases expression |
ISO |
10 |
74,033,677 |
74,035,797 |
RGD:6480464 |
CTD |
| G |
DDX26B |
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 26B |
|
decreases expression |
ISO |
X |
134,654,555 |
134,716,460 |
RGD:6480464 |
CTD |
| G |
DDX6 |
DEAD (Asp-Glu-Ala-Asp) box helicase 6 |
|
increases expression |
ISO |
11 |
118,618,472 |
118,661,972 |
RGD:6480464 |
CTD |
| G |
DERL2 |
derlin 2 |
|
decreases expression |
ISO |
17 |
5,377,613 |
5,389,497 |
RGD:6480464 |
CTD |
| G |
DFFB |
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase) |
|
decreases expression |
ISO |
1 |
3,773,845 |
3,801,993 |
RGD:6480464 |
CTD |
| G |
DHX30 |
DEAH (Asp-Glu-Ala-His) box polypeptide 30 |
|
decreases expression |
ISO |
3 |
47,844,399 |
47,891,686 |
RGD:6480464 |
CTD |
| G |
DMTF1 |
cyclin D binding myb-like transcription factor 1 |
|
decreases expression |
ISO |
7 |
86,781,677 |
86,825,648 |
RGD:6480464 |
CTD |
| G |
DNA2 |
DNA replication helicase/nuclease 2 |
|
decreases expression |
ISO |
10 |
70,173,821 |
70,231,730 |
RGD:6480464 |
CTD |
| G |
DNAJB1 |
DnaJ (Hsp40) homolog, subfamily B, member 1 |
|
increases expression |
ISO |
19 |
14,625,582 |
14,629,201 |
RGD:6480464 |
CTD |
| G |
DNAJB9 |
DnaJ (Hsp40) homolog, subfamily B, member 9 |
|
increases expression |
ISO |
7 |
108,210,189 |
108,215,294 |
RGD:6480464 |
CTD |
| G |
DNAJC10 |
DnaJ (Hsp40) homolog, subfamily C, member 10 |
|
decreases expression |
ISO |
2 |
183,580,999 |
183,643,255 |
RGD:6480464 |
CTD |
| G |
DNAJC3 |
DnaJ (Hsp40) homolog, subfamily C, member 3 |
|
decreases expression |
ISO |
13 |
96,329,393 |
96,447,243 |
RGD:6480464 |
CTD |
| G |
DNMT1 |
DNA (cytosine-5-)-methyltransferase 1 |
|
multiple interactions |
EXP |
19 |
10,244,022 |
10,305,755 |
RGD:6480464 |
CTD |
| G |
DTL |
denticleless E3 ubiquitin protein ligase homolog (Drosophila) |
|
decreases expression |
ISO |
1 |
212,208,919 |
212,278,187 |
RGD:6480464 |
CTD |
| G |
DUSP1 |
dual specificity phosphatase 1 |
|
increases expression |
ISO |
5 |
172,195,093 |
172,198,203 |
RGD:6480464 |
CTD |
| G |
DUSP16 |
dual specificity phosphatase 16 |
|
increases expression |
ISO |
12 |
12,626,216 |
12,715,448 |
RGD:6480464 |
CTD |
| G |
DUSP2 |
dual specificity phosphatase 2 |
|
increases expression |
ISO |
2 |
96,808,908 |
96,811,179 |
RGD:6480464 |
CTD |
| G |
DUSP8 |
dual specificity phosphatase 8 |
|
increases expression |
ISO |
11 |
1,575,281 |
1,593,150 |
RGD:6480464 |
CTD |
| G |
DYRK3 |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3 |
|
decreases expression |
ISO |
1 |
206,808,881 |
206,822,542 |
RGD:6480464 |
CTD |
| G |
EDN1 |
endothelin 1 |
|
increases expression |
ISO |
6 |
12,290,529 |
12,297,427 |
RGD:6480464 |
CTD |
| G |
EFR3A |
EFR3 homolog A (S. cerevisiae) |
|
decreases expression |
ISO |
8 |
132,916,356 |
133,025,889 |
RGD:6480464 |
CTD |
| G |
EGFR |
epidermal growth factor receptor |
|
increases expression |
EXP |
7 |
55,086,725 |
55,275,031 |
RGD:6480464 |
CTD |
| G |
EGR1 |
early growth response 1 |
|
increases expression |
ISO |
5 |
137,801,181 |
137,805,004 |
RGD:6480464 |
CTD |
| G |
EGR2 |
early growth response 2 |
|
affects expression |
ISO |
10 |
64,571,756 |
64,578,927 |
RGD:6480464 |
CTD |
| G |
EGR2 |
early growth response 2 |
|
increases expression |
ISO |
10 |
64,571,756 |
64,578,927 |
RGD:6480464 |
CTD |
| G |
EHD2 |
EH-domain containing 2 |
|
increases expression |
ISO |
19 |
48,216,601 |
48,246,391 |
RGD:6480464 |
CTD |
| G |
EID1 |
EP300 interacting inhibitor of differentiation 1 |
|
decreases expression |
ISO |
15 |
49,170,290 |
49,172,380 |
RGD:6480464 |
CTD |
| G |
EIF5 |
eukaryotic translation initiation factor 5 |
|
decreases expression |
ISO |
14 |
103,800,339 |
103,811,362 |
RGD:6480464 |
CTD |
| G |
EMP1 |
epithelial membrane protein 1 |
|
increases expression |
ISO |
12 |
13,349,602 |
13,369,708 |
RGD:6480464 |
CTD |
| G |
ENC1 |
ectodermal-neural cortex 1 (with BTB domain) |
|
decreases expression |
ISO |
5 |
73,923,231 |
73,937,249 |
RGD:6480464 |
CTD |
| G |
EPHA2 |
EPH receptor A2 |
|
increases expression |
ISO |
1 |
16,450,832 |
16,482,582 |
RGD:6480464 |
CTD |
| G |
ERI2 |
ERI1 exoribonuclease family member 2 |
|
decreases expression |
ISO |
16 |
20,791,515 |
20,817,795 |
RGD:6480464 |
CTD |
| G |
ETAA1 |
Ewing tumor-associated antigen 1 |
|
decreases expression |
ISO |
2 |
67,624,442 |
67,637,533 |
RGD:6480464 |
CTD |
| G |
EVI5 |
ecotropic viral integration site 5 |
|
decreases expression |
ISO |
1 |
92,974,253 |
93,257,961 |
RGD:6480464 |
CTD |
| G |
EXOC8 |
exocyst complex component 8 |
|
decreases expression |
ISO |
1 |
231,468,482 |
231,473,578 |
RGD:6480464 |
CTD |
| G |
F3 |
coagulation factor III (thromboplastin, tissue factor) |
|
increases expression |
ISO |
1 |
94,994,732 |
95,007,413 |
RGD:6480464 |
CTD |
| G |
FABP4 |
fatty acid binding protein 4, adipocyte |
|
increases expression |
ISO |
8 |
82,390,732 |
82,395,473 |
RGD:6480464 |
CTD |
| G |
FAM126B |
family with sequence similarity 126, member B |
|
decreases expression |
ISO |
2 |
201,838,441 |
201,936,392 |
RGD:6480464 |
CTD |
| G |
FAM129B |
family with sequence similarity 129, member B |
|
increases expression |
ISO |
9 |
130,267,618 |
130,341,268 |
RGD:6480464 |
CTD |
| G |
FAM13C |
family with sequence similarity 13, member C |
|
decreases expression |
ISO |
10 |
61,005,889 |
61,122,661 |
RGD:6480464 |
CTD |
| G |
FAM149B1 |
family with sequence similarity 149, member B1 |
|
decreases expression |
ISO |
10 |
74,927,877 |
75,001,939 |
RGD:6480464 |
CTD |
| G |
FAM46C |
family with sequence similarity 46, member C |
|
increases expression |
ISO |
1 |
118,148,604 |
118,171,011 |
RGD:6480464 |
CTD |
| G |
FAM58BP |
family with sequence similarity 58, member B, pseudogene |
|
decreases expression |
ISO |
1 |
200,182,656 |
200,183,643 |
RGD:6480464 |
CTD |
| G |
FAM76B |
family with sequence similarity 76, member B |
|
decreases expression |
ISO |
11 |
95,502,106 |
95,522,954 |
RGD:6480464 |
CTD |
| G |
FAM92A1 |
family with sequence similarity 92, member A1 |
|
decreases expression |
ISO |
8 |
94,712,773 |
94,740,674 |
RGD:6480464 |
CTD |
| G |
FAS |
Fas cell surface death receptor |
|
affects response to substance |
EXP |
10 |
90,750,288 |
90,775,542 |
RGD:6480464 |
CTD |
| G |
FAS |
Fas cell surface death receptor |
|
increases expression |
ISO |
10 |
90,750,288 |
90,775,542 |
RGD:6480464 |
CTD |
| G |
FASN |
fatty acid synthase |
|
increases activity |
ISO |
17 |
80,036,214 |
80,056,106 |
RGD:6480464 |
CTD |
| G |
FBXO15 |
F-box protein 15 |
|
increases expression |
ISO |
18 |
71,740,588 |
71,815,100 |
RGD:6480464 |
CTD |
| G |
FBXO21 |
F-box protein 21 |
|
decreases expression |
ISO |
12 |
117,581,585 |
117,628,300 |
RGD:6480464 |
CTD |
| G |
FBXO9 |
F-box protein 9 |
|
decreases expression |
ISO |
6 |
52,929,796 |
52,965,671 |
RGD:6480464 |
CTD |
| G |
FEM1B |
fem-1 homolog b (C. elegans) |
|
increases expression |
ISO |
15 |
68,570,141 |
68,583,640 |
RGD:6480464 |
CTD |
| G |
FGFR1OP2 |
FGFR1 oncogene partner 2 |
|
decreases expression |
ISO |
12 |
27,091,305 |
27,119,581 |
RGD:6480464 |
CTD |
| G |
FNBP4 |
formin binding protein 4 |
|
decreases expression |
ISO |
11 |
47,738,069 |
47,788,993 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
increases expression |
ISO |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
increases expression |
ISO |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
increases expression |
EXP |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
multiple interactions |
ISO |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOSB |
FBJ murine osteosarcoma viral oncogene homolog B |
|
increases expression |
ISO |
19 |
45,971,253 |
45,978,437 |
RGD:6480464 |
CTD |
| G |
FOSL1 |
FOS-like antigen 1 |
|
increases expression |
ISO |
11 |
65,659,692 |
65,667,997 |
RGD:6480464 |
CTD |
| G |
FPR1 |
formyl peptide receptor 1 |
|
increases expression |
ISO |
19 |
52,249,023 |
52,255,150 |
RGD:6480464 |
CTD |
| G |
FRMD4B |
FERM domain containing 4B |
|
decreases expression |
ISO |
3 |
69,219,146 |
69,435,430 |
RGD:6480464 |
CTD |
| G |
FUBP1 |
far upstream element (FUSE) binding protein 1 |
|
decreases expression |
ISO |
1 |
78,413,591 |
78,444,777 |
RGD:6480464 |
CTD |
| G |
FUS |
fused in sarcoma |
|
decreases expression |
ISO |
16 |
31,191,431 |
31,206,192 |
RGD:6480464 |
CTD |
| G |
FYCO1 |
FYVE and coiled-coil domain containing 1 |
|
decreases expression |
ISO |
3 |
45,959,391 |
46,037,316 |
RGD:6480464 |
CTD |
| G |
FZD5 |
frizzled family receptor 5 |
|
increases expression |
ISO |
2 |
208,627,310 |
208,634,143 |
RGD:6480464 |
CTD |
| G |
GADD45B |
growth arrest and DNA-damage-inducible, beta |
|
increases expression |
ISO |
19 |
2,476,123 |
2,478,257 |
RGD:6480464 |
CTD |
| G |
GAS2 |
growth arrest-specific 2 |
|
decreases expression |
ISO |
11 |
22,688,160 |
22,834,547 |
RGD:6480464 |
CTD |
| G |
GAS5 |
growth arrest-specific 5 (non-protein coding) |
|
decreases expression |
ISO |
1 |
173,833,039 |
173,837,125 |
RGD:6480464 |
CTD |
| G |
GCH1 |
GTP cyclohydrolase 1 |
|
increases expression |
ISO |
14 |
55,308,723 |
55,369,542 |
RGD:6480464 |
CTD |
| G |
GDF15 |
growth differentiation factor 15 |
|
increases expression |
ISO |
19 |
18,496,968 |
18,499,986 |
RGD:6480464 |
CTD |
| G |
GEM |
GTP binding protein overexpressed in skeletal muscle |
|
increases expression |
ISO |
8 |
95,261,481 |
95,274,547 |
RGD:6480464 |
CTD |
| G |
GFI1 |
growth factor independent 1 transcription repressor |
|
decreases expression |
ISO |
1 |
92,940,318 |
92,952,433 |
RGD:6480464 |
CTD |
| G |
GLA |
galactosidase, alpha |
|
increases expression |
ISO |
X |
100,652,779 |
100,663,001 |
RGD:6480464 |
CTD |
| G |
GLO1 |
glyoxalase I |
|
decreases activity |
EXP |
6 |
38,643,701 |
38,670,952 |
RGD:6480464 |
CTD |
| G |
GLO1 |
glyoxalase I |
|
decreases expression |
EXP |
6 |
38,643,701 |
38,670,952 |
RGD:6480464 |
CTD |
| G |
GMCL1 |
germ cell-less, spermatogenesis associated 1 |
|
decreases expression |
ISO |
2 |
70,056,818 |
70,106,727 |
RGD:6480464 |
CTD |
| G |
GPR137B |
G protein-coupled receptor 137B |
|
increases expression |
ISO |
1 |
236,305,832 |
236,372,209 |
RGD:6480464 |
CTD |
| G |
GPR155 |
G protein-coupled receptor 155 |
|
decreases expression |
ISO |
2 |
175,296,299 |
175,351,816 |
RGD:6480464 |
CTD |
| G |
GPR180 |
G protein-coupled receptor 180 |
|
decreases expression |
ISO |
13 |
95,254,104 |
95,286,899 |
RGD:6480464 |
CTD |
| G |
GPR65 |
G protein-coupled receptor 65 |
|
decreases expression |
ISO |
14 |
88,471,468 |
88,481,155 |
RGD:6480464 |
CTD |
| G |
GPR84 |
G protein-coupled receptor 84 |
|
decreases expression |
ISO |
12 |
54,756,229 |
54,758,270 |
RGD:6480464 |
CTD |
| G |
GSAP |
gamma-secretase activating protein |
|
decreases expression |
ISO |
7 |
76,940,068 |
77,045,717 |
RGD:6480464 |
CTD |
| G |
GSG2 |
germ cell associated 2 (haspin) |
|
decreases expression |
ISO |
17 |
3,627,197 |
3,629,993 |
RGD:6480464 |
CTD |
| G |
GSR |
glutathione reductase |
|
increases activity |
EXP |
8 |
30,535,578 |
30,585,486 |
RGD:6480464 |
CTD |
| G |
GSTP1 |
glutathione S-transferase pi 1 |
|
increases expression |
EXP |
11 |
67,351,066 |
67,354,124 |
RGD:6480464 |
CTD |
| G |
H2AFX |
H2A histone family, member X |
|
increases phosphorylation |
ISO |
11 |
118,964,584 |
118,966,177 |
RGD:6480464 |
CTD |
| G |
HAGH |
hydroxyacylglutathione hydrolase |
|
decreases expression |
EXP |
16 |
1,859,104 |
1,877,195 |
RGD:6480464 |
CTD |
| G |
HBEGF |
heparin-binding EGF-like growth factor |
|
increases expression |
ISO |
5 |
139,712,428 |
139,726,188 |
RGD:6480464 |
CTD |
| G |
HELZ |
helicase with zinc finger |
|
decreases expression |
ISO |
17 |
65,066,554 |
65,241,319 |
RGD:6480464 |
CTD |
| G |
HHEX |
hematopoietically expressed homeobox |
|
decreases expression |
ISO |
10 |
94,449,681 |
94,455,408 |
RGD:6480464 |
CTD |
| G |
HILPDA |
hypoxia inducible lipid droplet-associated |
|
increases expression |
ISO |
7 |
128,095,884 |
128,098,472 |
RGD:6480464 |
CTD |
| G |
HIPK3 |
homeodomain interacting protein kinase 3 |
|
decreases expression |
ISO |
11 |
33,279,168 |
33,375,939 |
RGD:6480464 |
CTD |
| G |
HIST1H1C |
histone cluster 1, H1c |
|
increases expression |
ISO |
6 |
26,055,968 |
26,056,699 |
RGD:6480464 |
CTD |
| G |
HIST1H2BC |
histone cluster 1, H2bc |
|
increases expression |
ISO |
6 |
26,123,695 |
26,124,132 |
RGD:6480464 |
CTD |
| G |
HIST1H2BD |
histone cluster 1, H2bd |
|
increases expression |
ISO |
6 |
26,158,349 |
26,171,577 |
RGD:6480464 |
CTD |
| G |
HIST1H2BO |
histone cluster 1, H2bo |
|
increases expression |
ISO |
6 |
27,861,203 |
27,861,669 |
RGD:6480464 |
CTD |
| G |
HIST1H3A |
histone cluster 1, H3a |
|
increases expression |
ISO |
6 |
26,020,718 |
26,021,186 |
RGD:6480464 |
CTD |
| G |
HIST1H3D |
histone cluster 1, H3d |
|
increases expression |
ISO |
6 |
26,197,012 |
26,199,464 |
RGD:6480464 |
CTD |
| G |
HIST2H2BB |
histone cluster 2, H2bb (pseudogene) |
|
increases expression |
ISO |
1 |
149,398,799 |
149,399,179 |
RGD:6480464 |
CTD |
| G |
HIST2H3C |
histone cluster 2, H3c |
|
increases expression |
ISO |
1 |
149,812,259 |
149,812,765 |
RGD:6480464 |
CTD |
| G |
HIST3H2A |
histone cluster 3, H2a |
|
increases expression |
ISO |
1 |
228,645,065 |
228,645,560 |
RGD:6480464 |
CTD |
| G |
HMGA2 |
high mobility group AT-hook 2 |
|
increases expression |
ISO |
12 |
66,218,240 |
66,360,071 |
RGD:6480464 |
CTD |
| G |
HMGCS1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) |
|
increases expression |
ISO |
5 |
43,287,572 |
43,313,614 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HNRNPA2B1 |
heterogeneous nuclear ribonucleoprotein A2/B1 |
|
decreases expression |
ISO |
7 |
26,229,556 |
26,240,413 |
RGD:6480464 |
CTD |
| G |
HNRNPU |
heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A) |
|
decreases expression |
ISO |
1 |
245,013,602 |
245,027,827 |
RGD:6480464 |
CTD |
| G |
HOXA1 |
homeobox A1 |
|
decreases expression |
ISO |
7 |
27,132,612 |
27,135,625 |
RGD:6480464 |
CTD |
| G |
HPGD |
hydroxyprostaglandin dehydrogenase 15-(NAD) |
|
decreases expression |
ISO |
4 |
175,411,328 |
175,444,049 |
RGD:6480464 |
CTD |
| G |
HPS3 |
Hermansky-Pudlak syndrome 3 |
|
decreases expression |
ISO |
3 |
148,847,371 |
148,891,305 |
RGD:6480464 |
CTD |
| G |
HSD17B7 |
hydroxysteroid (17-beta) dehydrogenase 7 |
|
increases expression |
ISO |
1 |
162,760,496 |
162,782,608 |
RGD:6480464 |
CTD |
| G |
HSPA5 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) |
|
increases expression |
EXP |
9 |
127,997,127 |
128,003,666 |
RGD:6480464 |
CTD |
| G |
HSPA5 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) |
|
multiple interactions |
EXP |
9 |
127,997,127 |
128,003,666 |
RGD:6480464 |
CTD |
| G |
HSPA8 |
heat shock 70kDa protein 8 |
|
increases expression |
ISO |
11 |
122,928,200 |
122,932,901 |
RGD:6480464 |
CTD |
| G |
HYOU1 |
hypoxia up-regulated 1 |
|
decreases expression |
ISO |
11 |
118,914,896 |
118,927,925 |
RGD:6480464 |
CTD |
| G |
ICAM1 |
intercellular adhesion molecule 1 |
|
increases expression |
EXP |
19 |
10,381,517 |
10,397,291 |
RGD:6480464 |
CTD |
| G |
ID2 |
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein |
|
increases expression |
ISO |
2 |
8,822,113 |
8,824,583 |
RGD:6480464 |
CTD |
| G |
IER2 |
immediate early response 2 |
|
increases expression |
ISO |
19 |
13,261,282 |
13,265,722 |
RGD:6480464 |
CTD |
| G |
IER3 |
immediate early response 3 |
|
increases expression |
ISO |
6 |
30,710,976 |
30,712,327 |
RGD:6480464 |
CTD |
| G |
IER5 |
immediate early response 5 |
|
increases expression |
ISO |
1 |
181,057,638 |
181,059,979 |
RGD:6480464 |
CTD |
| G |
IFIT2 |
interferon-induced protein with tetratricopeptide repeats 2 |
|
decreases expression |
ISO |
10 |
91,061,706 |
91,069,033 |
RGD:6480464 |
CTD |
| G |
IFNA2 |
interferon, alpha 2 |
|
decreases expression |
EXP |
9 |
21,384,254 |
21,385,396 |
RGD:6480464 |
CTD |
| G |
IFNG |
interferon, gamma |
|
multiple interactions |
ISO |
12 |
68,548,550 |
68,553,521 |
RGD:6480464 |
CTD |
| G |
IFNG |
interferon, gamma |
|
decreases secretion |
ISO |
12 |
68,548,550 |
68,553,521 |
RGD:6480464 |
CTD |
| G |
IFRD1 |
interferon-related developmental regulator 1 |
|
increases expression |
ISO |
7 |
112,063,199 |
112,117,258 |
RGD:6480464 |
CTD |
| G |
IGF1 |
insulin-like growth factor 1 (somatomedin C) |
|
decreases expression |
ISO |
12 |
102,789,645 |
102,874,378 |
RGD:6480464 |
CTD |
| G |
IGF2BP2 |
insulin-like growth factor 2 mRNA binding protein 2 |
|
increases expression |
ISO |
3 |
185,361,527 |
185,542,827 |
RGD:6480464 |
CTD |
| G |
IGSF6 |
immunoglobulin superfamily, member 6 |
|
decreases expression |
ISO |
16 |
21,652,605 |
21,663,987 |
RGD:6480464 |
CTD |
| G |
IKBIP |
IKBKB interacting protein |
|
decreases expression |
ISO |
12 |
99,007,182 |
99,038,829 |
RGD:6480464 |
CTD |
| G |
IL10 |
interleukin 10 |
|
multiple interactions |
ISO |
1 |
206,940,948 |
206,945,839 |
RGD:6480464 |
CTD |
| G |
IL10 |
interleukin 10 |
|
decreases response to substance |
ISO |
1 |
206,940,948 |
206,945,839 |
RGD:6480464 |
CTD |
| G |
IL10 |
interleukin 10 |
|
decreases secretion |
ISO |
1 |
206,940,948 |
206,945,839 |
RGD:6480464 |
CTD |
| G |
IL10 |
interleukin 10 |
|
increases expression |
ISO |
1 |
206,940,948 |
206,945,839 |
RGD:6480464 |
CTD |
| G |
IL10 |
interleukin 10 |
|
multiple interactions |
ISO |
1 |
206,940,948 |
206,945,839 |
RGD:6480464 |
CTD |
| G |
IL10 |
interleukin 10 |
|
multiple interactions |
ISO |
1 |
206,940,948 |
206,945,839 |
RGD:6480464 |
CTD |
| G |
IL10 |
interleukin 10 |
|
multiple interactions |
ISO |
1 |
206,940,948 |
206,945,839 |
RGD:6480464 |
CTD |
| G |
IL11 |
interleukin 11 |
|
increases expression |
ISO |
19 |
55,875,750 |
55,881,831 |
RGD:6480464 |
CTD |
| G |
IL12A |
interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) |
|
multiple interactions |
ISO |
3 |
159,706,623 |
159,713,806 |
RGD:6480464 |
CTD |
| G |
IL12A |
interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) |
|
increases response to substance |
ISO |
3 |
159,706,623 |
159,713,806 |
RGD:6480464 |
CTD |
| G |
IL12B |
interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) |
|
multiple interactions |
ISO |
5 |
158,741,791 |
158,757,481 |
RGD:6480464 |
CTD |
| G |
IL12B |
interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) |
|
decreases response to substance |
ISO |
5 |
158,741,791 |
158,757,481 |
RGD:6480464 |
CTD |
| G |
IL12B |
interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) |
|
affects response to substance |
ISO |
5 |
158,741,791 |
158,757,481 |
RGD:6480464 |
CTD |
| G |
IL13RA1 |
interleukin 13 receptor, alpha 1 |
|
decreases expression |
ISO |
X |
117,861,559 |
117,928,496 |
RGD:6480464 |
CTD |
| G |
IL13RA1 |
interleukin 13 receptor, alpha 1 |
|
decreases expression |
ISO |
X |
117,861,559 |
117,928,496 |
RGD:6480464 |
CTD |
| G |
IL16 |
interleukin 16 |
|
decreases expression |
ISO |
15 |
81,489,219 |
81,605,104 |
RGD:6480464 |
CTD |
| G |
IL17A |
interleukin 17A |
|
multiple interactions |
ISO |
6 |
52,051,185 |
52,055,436 |
RGD:6480464 |
CTD |
| G |
IL17A |
interleukin 17A |
|
increases expression |
ISO |
6 |
52,051,185 |
52,055,436 |
RGD:6480464 |
CTD |
| G |
IL17A |
interleukin 17A |
|
increases expression |
ISO |
6 |
52,051,185 |
52,055,436 |
RGD:6480464 |
CTD |
| G |
IL17A |
interleukin 17A |
|
multiple interactions |
ISO |
6 |
52,051,185 |
52,055,436 |
RGD:6480464 |
CTD |
| G |
IL17F |
interleukin 17F |
|
increases expression |
ISO |
6 |
52,101,484 |
52,109,298 |
RGD:6480464 |
CTD |
| G |
IL17RA |
interleukin 17 receptor A |
|
increases expression |
ISO |
22 |
17,565,851 |
17,596,584 |
RGD:6480464 |
CTD |
| G |
IL1A |
interleukin 1, alpha |
|
multiple interactions |
ISO |
2 |
113,531,492 |
113,542,971 |
RGD:6480464 |
CTD |
| G |
IL1A |
interleukin 1, alpha |
|
increases expression |
EXP |
2 |
113,531,492 |
113,542,971 |
RGD:6480464 |
CTD |
| G |
IL1A |
interleukin 1, alpha |
|
multiple interactions |
ISO |
2 |
113,531,492 |
113,542,971 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
multiple interactions |
ISO |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
increases expression |
ISO |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
increases expression |
ISO |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
increases expression |
EXP |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
multiple interactions |
EXP |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
increases secretion |
EXP |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
increases secretion |
ISO |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
increases expression |
ISO |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
multiple interactions |
ISO |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
multiple interactions |
EXP |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
multiple interactions |
ISO |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
multiple interactions |
ISO |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
increases expression |
ISO |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
increases expression |
ISO |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
multiple interactions |
ISO |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
increases expression |
ISO |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
multiple interactions |
ISO |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
increases secretion |
ISO |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
multiple interactions |
ISO |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1R1 |
interleukin 1 receptor, type I |
|
affects response to substance |
ISO |
2 |
102,770,402 |
102,796,334 |
RGD:6480464 |
CTD |
| G |
IL1RN |
interleukin 1 receptor antagonist |
|
increases expression |
ISO |
2 |
113,875,470 |
113,891,593 |
RGD:6480464 |
CTD |
| G |
IL1RN |
interleukin 1 receptor antagonist |
|
increases expression |
EXP |
2 |
113,875,470 |
113,891,593 |
RGD:6480464 |
CTD |
| G |
IL22 |
interleukin 22 |
|
multiple interactions |
ISO |
12 |
68,642,025 |
68,647,281 |
RGD:6480464 |
CTD |
| G |
IL23A |
interleukin 23, alpha subunit p19 |
|
multiple interactions |
ISO |
12 |
56,732,663 |
56,734,194 |
RGD:6480464 |
CTD |
| G |
IL23A |
interleukin 23, alpha subunit p19 |
|
increases expression |
ISO |
12 |
56,732,663 |
56,734,194 |
RGD:6480464 |
CTD |
| G |
IL36RN |
interleukin 36 receptor antagonist |
|
decreases expression |
EXP |
2 |
113,816,215 |
113,822,321 |
RGD:6480464 |
CTD |
| G |
IL37 |
interleukin 37 |
|
decreases expression |
EXP |
2 |
113,670,548 |
113,676,459 |
RGD:6480464 |
CTD |
| G |
IL4 |
interleukin 4 |
|
increases secretion |
ISO |
5 |
132,009,678 |
132,018,370 |
RGD:6480464 |
CTD |
| G |
IL4 |
interleukin 4 |
|
increases expression |
ISO |
5 |
132,009,678 |
132,018,370 |
RGD:6480464 |
CTD |
| G |
IL4 |
interleukin 4 |
|
multiple interactions |
ISO |
5 |
132,009,678 |
132,018,370 |
RGD:6480464 |
CTD |
| G |
IL4I1 |
interleukin 4 induced 1 |
|
decreases expression |
ISO |
19 |
50,392,911 |
50,432,796 |
RGD:6480464 |
CTD |
| G |
IL5 |
interleukin 5 (colony-stimulating factor, eosinophil) |
|
multiple interactions |
ISO |
5 |
131,877,136 |
131,879,214 |
RGD:6480464 |
CTD |
| G |
IL5 |
interleukin 5 (colony-stimulating factor, eosinophil) |
|
increases secretion |
ISO |
5 |
131,877,136 |
131,879,214 |
RGD:6480464 |
CTD |
| G |
IL5 |
interleukin 5 (colony-stimulating factor, eosinophil) |
|
increases expression |
ISO |
5 |
131,877,136 |
131,879,214 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
multiple interactions |
ISO |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
increases expression |
ISO |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
multiple interactions |
EXP |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
multiple interactions |
ISO |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
increases secretion |
ISO |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
increases secretion |
EXP |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
multiple interactions |
ISO |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
multiple interactions |
ISO |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
increases expression |
ISO |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
increases secretion |
ISO |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
increases secretion |
ISO |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
multiple interactions |
ISO |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
increases expression |
ISO |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
increases secretion |
ISO |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
multiple interactions |
EXP |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
increases expression |
EXP |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
increases secretion |
EXP |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6R |
interleukin 6 receptor |
|
multiple interactions |
ISO |
1 |
154,377,669 |
154,441,926 |
RGD:6480464 |
CTD |
| G |
IL6R |
interleukin 6 receptor |
|
affects response to substance |
ISO |
1 |
154,377,669 |
154,441,926 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
increases secretion |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
increases expression |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
multiple interactions |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
increases expression |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
multiple interactions |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
increases secretion |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
increases expression |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
IMPAD1 |
inositol monophosphatase domain containing 1 |
|
decreases expression |
ISO |
8 |
57,870,488 |
57,906,430 |
RGD:6480464 |
CTD |
| G |
IPO8 |
importin 8 |
|
decreases expression |
ISO |
12 |
30,781,915 |
30,848,929 |
RGD:6480464 |
CTD |
| G |
IRF2 |
interferon regulatory factor 2 |
|
decreases expression |
ISO |
4 |
185,308,876 |
185,395,726 |
RGD:6480464 |
CTD |
| G |
IRG1 |
immunoresponsive 1 homolog (mouse) |
|
increases expression |
ISO |
13 |
77,522,694 |
77,532,777 |
RGD:6480464 |
CTD |
| G |
IRG1 |
immunoresponsive 1 homolog (mouse) |
|
increases expression |
ISO |
13 |
77,522,694 |
77,532,777 |
RGD:6480464 |
CTD |
| G |
ITFG1 |
integrin alpha FG-GAP repeat containing 1 |
|
decreases expression |
ISO |
16 |
47,189,297 |
47,495,018 |
RGD:6480464 |
CTD |
| G |
ITGA5 |
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) |
|
increases expression |
ISO |
12 |
54,789,045 |
54,813,050 |
RGD:6480464 |
CTD |
| G |
JMJD1C |
jumonji domain containing 1C |
|
increases expression |
ISO |
10 |
64,926,985 |
65,225,722 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
increases expression |
ISO |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
increases expression |
EXP |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
JUNB |
jun B proto-oncogene |
|
increases expression |
ISO |
19 |
12,902,310 |
12,904,125 |
RGD:6480464 |
CTD |
| G |
JUNB |
jun B proto-oncogene |
|
increases expression |
ISO |
19 |
12,902,310 |
12,904,125 |
RGD:6480464 |
CTD |
| G |
JUND |
jun D proto-oncogene |
|
increases expression |
ISO |
19 |
18,390,563 |
18,392,432 |
RGD:6480464 |
CTD |
| G |
KDM5D |
lysine (K)-specific demethylase 5D |
|
decreases expression |
ISO |
Y |
21,867,301 |
21,906,825 |
RGD:6480464 |
CTD |
| G |
KIF18A |
kinesin family member 18A |
|
decreases expression |
ISO |
11 |
28,042,163 |
28,129,746 |
RGD:6480464 |
CTD |
| G |
KLF2 |
Kruppel-like factor 2 (lung) |
|
increases expression |
ISO |
19 |
16,435,651 |
16,438,345 |
RGD:6480464 |
CTD |
| G |
KLF3 |
Kruppel-like factor 3 (basic) |
|
increases expression |
ISO |
4 |
38,665,790 |
38,703,129 |
RGD:6480464 |
CTD |
| G |
KLF4 |
Kruppel-like factor 4 (gut) |
|
decreases expression |
ISO |
9 |
110,247,133 |
110,252,047 |
RGD:6480464 |
CTD |
| G |
KLF6 |
Kruppel-like factor 6 |
|
increases expression |
ISO |
10 |
3,818,188 |
3,827,473 |
RGD:6480464 |
CTD |
| G |
KLF7 |
Kruppel-like factor 7 (ubiquitous) |
|
increases expression |
ISO |
2 |
207,938,861 |
208,031,970 |
RGD:6480464 |
CTD |
| G |
KLF9 |
Kruppel-like factor 9 |
|
increases expression |
ISO |
9 |
72,999,513 |
73,029,573 |
RGD:6480464 |
CTD |
| G |
KLHL42 |
kelch-like family member 42 |
|
decreases expression |
ISO |
12 |
27,933,187 |
27,955,973 |
RGD:6480464 |
CTD |
| G |
LDHC |
lactate dehydrogenase C |
|
increases expression |
ISO |
11 |
18,433,853 |
18,472,793 |
RGD:6480464 |
CTD |
| G |
LGALS3 |
lectin, galactoside-binding, soluble, 3 |
|
increases expression |
ISO |
14 |
55,595,935 |
55,612,148 |
RGD:6480464 |
CTD |
| G |
LIF |
leukemia inhibitory factor |
|
increases expression |
ISO |
22 |
30,636,436 |
30,642,840 |
RGD:6480464 |
CTD |
| G |
LIF |
leukemia inhibitory factor |
|
multiple interactions |
ISO |
22 |
30,636,436 |
30,642,840 |
RGD:6480464 |
CTD |
| G |
LILRB4 |
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4 |
|
increases expression |
ISO |
19 |
55,174,124 |
55,179,848 |
RGD:6480464 |
CTD |
| G |
LIPT2 |
lipoyl(octanoyl) transferase 2 (putative) |
|
decreases expression |
ISO |
11 |
74,202,923 |
74,204,755 |
RGD:6480464 |
CTD |
| G |
LITAF |
lipopolysaccharide-induced TNF factor |
|
increases expression |
ISO |
16 |
11,641,578 |
11,681,322 |
RGD:6480464 |
CTD |
| G |
LPIN1 |
lipin 1 |
|
increases expression |
ISO |
2 |
11,817,705 |
11,967,535 |
RGD:6480464 |
CTD |
| G |
LRR1 |
leucine rich repeat protein 1 |
|
decreases expression |
ISO |
14 |
50,065,415 |
50,081,390 |
RGD:6480464 |
CTD |
| G |
LRRC14 |
leucine rich repeat containing 14 |
|
decreases expression |
ISO |
8 |
145,743,363 |
145,750,562 |
RGD:6480464 |
CTD |
| G |
LRRK1 |
leucine-rich repeat kinase 1 |
|
decreases expression |
ISO |
15 |
101,459,460 |
101,610,317 |
RGD:6480464 |
CTD |
| G |
LTA |
lymphotoxin alpha (TNF superfamily, member 1) |
|
decreases expression |
EXP |
6 |
31,539,876 |
31,542,101 |
RGD:6480464 |
CTD |
| G |
LTB |
lymphotoxin beta (TNF superfamily, member 3) |
|
increases expression |
EXP |
6 |
31,548,335 |
31,550,202 |
RGD:6480464 |
CTD |
| G |
LUC7L2 |
LUC7-like 2 (S. cerevisiae) |
|
decreases expression |
ISO |
7 |
139,025,105 |
139,108,203 |
RGD:6480464 |
CTD |
| G |
LUC7L2 |
LUC7-like 2 (S. cerevisiae) |
|
decreases expression |
ISO |
7 |
139,025,105 |
139,108,203 |
RGD:6480464 |
CTD |
| G |
LYRM2 |
LYR motif containing 2 |
|
decreases expression |
ISO |
6 |
90,341,943 |
90,348,474 |
RGD:6480464 |
CTD |
| G |
LYRM5 |
LYR motif containing 5 |
|
decreases expression |
ISO |
12 |
25,348,150 |
25,357,949 |
RGD:6480464 |
CTD |
| G |
MAFF |
v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) |
|
increases expression |
ISO |
22 |
38,597,939 |
38,612,518 |
RGD:6480464 |
CTD |
| G |
MAFK |
v-maf musculoaponeurotic fibrosarcoma oncogene homolog K (avian) |
|
increases expression |
ISO |
7 |
1,570,368 |
1,582,679 |
RGD:6480464 |
CTD |
| G |
MALAT1 |
metastasis associated lung adenocarcinoma transcript 1 (non-protein coding) |
|
increases expression |
ISO |
11 |
65,265,233 |
65,273,940 |
RGD:6480464 |
CTD |
| G |
MAN2B1 |
mannosidase, alpha, class 2B, member 1 |
|
decreases expression |
ISO |
19 |
12,757,322 |
12,777,591 |
RGD:6480464 |
CTD |
| G |
MAP1LC3B |
microtubule-associated protein 1 light chain 3 beta |
|
increases expression |
ISO |
16 |
87,425,801 |
87,438,380 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
increases phosphorylation |
EXP |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK8 |
mitogen-activated protein kinase 8 |
|
decreases expression |
ISO |
10 |
49,609,687 |
49,643,183 |
RGD:6480464 |
CTD |
| G |
MARCO |
macrophage receptor with collagenous structure |
|
multiple interactions |
ISO |
2 |
119,699,745 |
119,752,236 |
RGD:6480464 |
CTD |
| G |
MARCO |
macrophage receptor with collagenous structure |
|
affects binding |
EXP |
2 |
119,699,745 |
119,752,236 |
RGD:6480464 |
CTD |
| G |
MARCO |
macrophage receptor with collagenous structure |
|
increases expression |
ISO |
2 |
119,699,745 |
119,752,236 |
RGD:6480464 |
CTD |
| G |
MAVS |
mitochondrial antiviral signaling protein |
|
decreases expression |
ISO |
20 |
3,827,446 |
3,856,770 |
RGD:6480464 |
CTD |
| G |
MBP |
myelin basic protein |
|
decreases expression |
ISO |
18 |
74,690,789 |
74,844,774 |
RGD:6480464 |
CTD |
| G |
MDM2 |
MDM2 oncogene, E3 ubiquitin protein ligase |
|
increases expression |
ISO |
12 |
69,201,971 |
69,239,320 |
RGD:6480464 |
CTD |
| G |
MDP1 |
magnesium-dependent phosphatase 1 |
|
decreases expression |
ISO |
14 |
24,683,143 |
24,685,276 |
RGD:6480464 |
CTD |
| G |
MEF2C |
myocyte enhancer factor 2C |
|
decreases expression |
ISO |
5 |
88,014,058 |
88,199,922 |
RGD:6480464 |
CTD |
| G |
METRNL |
meteorin, glial cell differentiation regulator-like |
|
increases expression |
ISO |
17 |
81,037,567 |
81,052,592 |
RGD:6480464 |
CTD |
| G |
METTL21A |
methyltransferase like 21A |
|
decreases expression |
ISO |
2 |
208,473,839 |
208,489,973 |
RGD:6480464 |
CTD |
| G |
METTL7A |
methyltransferase like 7A |
|
decreases expression |
ISO |
12 |
51,318,534 |
51,326,300 |
RGD:6480464 |
CTD |
| G |
MFSD6 |
major facilitator superfamily domain containing 6 |
|
decreases expression |
ISO |
2 |
191,273,081 |
191,367,041 |
RGD:6480464 |
CTD |
| G |
MGAT2 |
mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
|
decreases expression |
ISO |
14 |
50,087,489 |
50,090,199 |
RGD:6480464 |
CTD |
| G |
MINA |
MYC induced nuclear antigen |
|
increases expression |
EXP |
3 |
97,660,661 |
97,691,295 |
RGD:6480464 |
CTD |
| G |
MMP8 |
matrix metallopeptidase 8 (neutrophil collagenase) |
|
increases expression |
ISO |
11 |
102,582,526 |
102,595,685 |
RGD:6480464 |
CTD |
| G |
MMP9 |
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
|
increases expression |
ISO |
20 |
44,637,547 |
44,645,200 |
RGD:6480464 |
CTD |
| G |
MMP9 |
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
|
multiple interactions |
EXP |
20 |
44,637,547 |
44,645,200 |
RGD:6480464 |
CTD |
| G |
MMP9 |
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
|
increases expression |
EXP |
20 |
44,637,547 |
44,645,200 |
RGD:6480464 |
CTD |
| G |
MOCS2 |
molybdenum cofactor synthesis 2 |
|
decreases expression |
ISO |
5 |
52,393,892 |
52,405,598 |
RGD:6480464 |
CTD |
| G |
MPO |
myeloperoxidase |
|
increases activity |
ISO |
17 |
56,347,217 |
56,358,296 |
RGD:6480464 |
CTD |
| G |
MPO |
myeloperoxidase |
|
multiple interactions |
ISO |
17 |
56,347,217 |
56,358,296 |
RGD:6480464 |
CTD |
| G |
MRPL15 |
mitochondrial ribosomal protein L15 |
|
decreases expression |
ISO |
8 |
55,047,781 |
55,061,074 |
RGD:6480464 |
CTD |
| G |
MRPL50 |
mitochondrial ribosomal protein L50 |
|
decreases expression |
ISO |
9 |
104,152,249 |
104,160,919 |
RGD:6480464 |
CTD |
| G |
MST1R |
macrophage stimulating 1 receptor (c-met-related tyrosine kinase) |
|
increases expression |
ISO |
3 |
49,924,435 |
49,941,306 |
RGD:6480464 |
CTD |
| G |
MT1A |
metallothionein 1A |
|
increases expression |
ISO |
16 |
56,672,578 |
56,673,999 |
RGD:6480464 |
CTD |
| G |
MTMR4 |
myotubularin related protein 4 |
|
decreases expression |
ISO |
17 |
56,566,893 |
56,595,251 |
RGD:6480464 |
CTD |
| G |
MTMR9 |
myotubularin related protein 9 |
|
decreases expression |
ISO |
8 |
11,142,000 |
11,185,655 |
RGD:6480464 |
CTD |
| G |
MVD |
mevalonate (diphospho) decarboxylase |
|
increases expression |
ISO |
16 |
88,718,348 |
88,729,495 |
RGD:6480464 |
CTD |
| G |
MYD88 |
myeloid differentiation primary response 88 |
|
increases expression |
ISO |
3 |
38,179,969 |
38,184,513 |
RGD:6480464 |
CTD |
| G |
MYD88 |
myeloid differentiation primary response 88 |
|
multiple interactions |
ISO |
3 |
38,179,969 |
38,184,513 |
RGD:6480464 |
CTD |
| G |
MYO10 |
myosin X |
|
increases expression |
ISO |
5 |
16,662,016 |
16,936,385 |
RGD:6480464 |
CTD |
| G |
NAB2 |
NGFI-A binding protein 2 (EGR1 binding protein 2) |
|
increases expression |
ISO |
12 |
57,482,677 |
57,489,259 |
RGD:6480464 |
CTD |
| G |
NABP1 |
nucleic acid binding protein 1 |
|
increases expression |
ISO |
2 |
192,542,798 |
192,553,248 |
RGD:6480464 |
CTD |
| G |
NANP |
N-acetylneuraminic acid phosphatase |
|
decreases expression |
ISO |
20 |
25,593,571 |
25,604,648 |
RGD:6480464 |
CTD |
| G |
NAP1L1 |
nucleosome assembly protein 1-like 1 |
|
decreases expression |
ISO |
12 |
76,438,672 |
76,478,738 |
RGD:6480464 |
CTD |
| G |
NAT2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
decreases expression |
ISO |
8 |
18,248,755 |
18,258,723 |
RGD:6480464 |
CTD |
| G |
NCF1 |
neutrophil cytosolic factor 1 |
|
increases expression |
ISO |
7 |
74,188,309 |
74,203,659 |
RGD:6480464 |
CTD |
| G |
NCF2 |
neutrophil cytosolic factor 2 |
|
increases expression |
ISO |
1 |
183,524,697 |
183,560,056 |
RGD:6480464 |
CTD |
| G |
NDEL1 |
nudE nuclear distribution E homolog (A. nidulans)-like 1 |
|
increases expression |
ISO |
17 |
8,339,170 |
8,371,495 |
RGD:6480464 |
CTD |
| G |
NDRG1 |
N-myc downstream regulated 1 |
|
increases expression |
ISO |
8 |
134,249,414 |
134,309,547 |
RGD:6480464 |
CTD |
| G |
NDUFAB1 |
NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1, 8kDa |
|
decreases expression |
ISO |
16 |
23,592,335 |
23,607,639 |
RGD:6480464 |
CTD |
| G |
NEDD4L |
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase |
|
increases expression |
ISO |
18 |
55,711,610 |
56,068,772 |
RGD:6480464 |
CTD |
| G |
NFAM1 |
NFAT activating protein with ITAM motif 1 |
|
decreases expression |
ISO |
22 |
42,776,413 |
42,828,401 |
RGD:6480464 |
CTD |
| G |
NFE2L2 |
nuclear factor (erythroid-derived 2)-like 2 |
|
increases expression |
ISO |
2 |
178,095,031 |
178,129,859 |
RGD:6480464 |
CTD |
| G |
NFE2L2 |
nuclear factor (erythroid-derived 2)-like 2 |
|
multiple interactions |
EXP |
2 |
178,095,031 |
178,129,859 |
RGD:6480464 |
CTD |
| G |
NFIL3 |
nuclear factor, interleukin 3 regulated |
|
increases expression |
ISO |
9 |
94,171,327 |
94,186,144 |
RGD:6480464 |
CTD |
| G |
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
affects response to substance |
EXP |
4 |
103,422,486 |
103,538,459 |
RGD:6480464 |
CTD |
| G |
NFKBIE |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon |
|
decreases expression |
ISO |
6 |
44,225,903 |
44,233,525 |
RGD:6480464 |
CTD |
| G |
NFKBIZ |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta |
|
increases expression |
ISO |
3 |
101,546,834 |
101,579,869 |
RGD:6480464 |
CTD |
| G |
NISCH |
nischarin |
|
decreases expression |
ISO |
3 |
52,489,524 |
52,527,088 |
RGD:6480464 |
CTD |
| G |
NKTR |
natural killer-tumor recognition sequence |
|
increases expression |
ISO |
3 |
42,642,147 |
42,690,233 |
RGD:6480464 |
CTD |
| G |
NLRP3 |
NLR family, pyrin domain containing 3 |
|
increases expression |
ISO |
1 |
247,579,458 |
247,612,410 |
RGD:6480464 |
CTD |
| G |
NLRP3 |
NLR family, pyrin domain containing 3 |
|
multiple interactions |
EXP |
1 |
247,579,458 |
247,612,410 |
RGD:6480464 |
CTD |
| G |
NLRP3 |
NLR family, pyrin domain containing 3 |
|
multiple interactions |
ISO |
1 |
247,579,458 |
247,612,410 |
RGD:6480464 |
CTD |
| G |
NONO |
non-POU domain containing, octamer-binding |
|
decreases expression |
ISO |
X |
70,503,042 |
70,521,018 |
RGD:6480464 |
CTD |
| G |
NOS2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
17 |
26,083,792 |
26,127,555 |
RGD:6480464 |
CTD |
| G |
NOS2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
17 |
26,083,792 |
26,127,555 |
RGD:6480464 |
CTD |
| G |
NOS2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
17 |
26,083,792 |
26,127,555 |
RGD:6480464 |
CTD |
| G |
NOS2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
17 |
26,083,792 |
26,127,555 |
RGD:6480464 |
CTD |
| G |
NR3C1 |
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
|
decreases expression |
ISO |
5 |
142,657,496 |
142,815,077 |
RGD:6480464 |
CTD |
| G |
NR4A1 |
nuclear receptor subfamily 4, group A, member 1 |
|
increases expression |
ISO |
12 |
52,416,616 |
52,453,291 |
RGD:6480464 |
CTD |
| G |
NR4A2 |
nuclear receptor subfamily 4, group A, member 2 |
|
increases expression |
ISO |
2 |
157,180,944 |
157,189,287 |
RGD:6480464 |
CTD |
| G |
NRP1 |
neuropilin 1 |
|
decreases expression |
ISO |
10 |
33,466,419 |
33,623,833 |
RGD:6480464 |
CTD |
| G |
NTMT1 |
N-terminal Xaa-Pro-Lys N-methyltransferase 1 |
|
increases expression |
ISO |
9 |
132,388,435 |
132,397,879 |
RGD:6480464 |
CTD |
| G |
NUDT7 |
nudix (nucleoside diphosphate linked moiety X)-type motif 7 |
|
decreases expression |
ISO |
16 |
77,756,389 |
77,776,157 |
RGD:6480464 |
CTD |
| G |
NUPR1 |
nuclear protein, transcriptional regulator, 1 |
|
increases expression |
ISO |
16 |
28,548,662 |
28,550,495 |
RGD:6480464 |
CTD |
| G |
ODC1 |
ornithine decarboxylase 1 |
|
increases expression |
ISO |
2 |
10,580,508 |
10,588,453 |
RGD:6480464 |
CTD |
| G |
OGFRL1 |
opioid growth factor receptor-like 1 |
|
decreases expression |
ISO |
6 |
71,998,477 |
72,011,973 |
RGD:6480464 |
CTD |
| G |
OGG1 |
8-oxoguanine DNA glycosylase |
|
increases expression |
ISO |
3 |
9,791,628 |
9,808,353 |
RGD:6480464 |
CTD |
| G |
OGT |
O-linked N-acetylglucosamine (GlcNAc) transferase |
|
decreases expression |
ISO |
X |
70,752,912 |
70,795,747 |
RGD:6480464 |
CTD |
| G |
OLR1 |
oxidized low density lipoprotein (lectin-like) receptor 1 |
|
decreases expression |
ISO |
12 |
10,310,899 |
10,324,790 |
RGD:6480464 |
CTD |
| G |
OLR1 |
oxidized low density lipoprotein (lectin-like) receptor 1 |
|
increases expression |
ISO |
12 |
10,310,899 |
10,324,790 |
RGD:6480464 |
CTD |
| G |
ORMDL1 |
ORM1-like 1 (S. cerevisiae) |
|
decreases expression |
ISO |
2 |
190,634,993 |
190,649,097 |
RGD:6480464 |
CTD |
| G |
OSBPL9 |
oxysterol binding protein-like 9 |
|
increases expression |
ISO |
1 |
52,082,546 |
52,254,891 |
RGD:6480464 |
CTD |
| G |
OSGIN1 |
oxidative stress induced growth inhibitor 1 |
|
increases expression |
ISO |
16 |
83,986,827 |
83,999,937 |
RGD:6480464 |
CTD |
| G |
OSGIN2 |
oxidative stress induced growth inhibitor family member 2 |
|
increases expression |
ISO |
8 |
90,914,096 |
90,940,096 |
RGD:6480464 |
CTD |
| G |
OXR1 |
oxidation resistance 1 |
|
decreases expression |
ISO |
8 |
107,282,406 |
107,764,922 |
RGD:6480464 |
CTD |
| G |
P2RX4 |
purinergic receptor P2X, ligand-gated ion channel, 4 |
|
increases expression |
ISO |
12 |
121,647,664 |
121,671,909 |
RGD:6480464 |
CTD |
| G |
P2RY12 |
purinergic receptor P2Y, G-protein coupled, 12 |
|
decreases expression |
ISO |
3 |
151,055,376 |
151,102,544 |
RGD:6480464 |
CTD |
| G |
PABPC1 |
poly(A) binding protein, cytoplasmic 1 |
|
decreases expression |
ISO |
8 |
101,715,144 |
101,734,315 |
RGD:6480464 |
CTD |
| G |
PAFAH1B1 |
platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa) |
|
increases expression |
ISO |
17 |
2,496,923 |
2,588,909 |
RGD:6480464 |
CTD |
| G |
PANK1 |
pantothenate kinase 1 |
|
decreases expression |
ISO |
10 |
91,339,254 |
91,405,329 |
RGD:6480464 |
CTD |
| G |
PAQR7 |
progestin and adipoQ receptor family member VII |
|
decreases expression |
ISO |
1 |
26,187,975 |
26,197,744 |
RGD:6480464 |
CTD |
| G |
PARD6B |
par-6 partitioning defective 6 homolog beta (C. elegans) |
|
increases expression |
ISO |
20 |
49,348,081 |
49,370,278 |
RGD:6480464 |
CTD |
| G |
PARP1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
EXP |
1 |
226,548,392 |
226,595,801 |
RGD:6480464 |
CTD |
| G |
PARP1 |
poly (ADP-ribose) polymerase 1 |
|
decreases expression |
EXP |
1 |
226,548,392 |
226,595,801 |
RGD:6480464 |
CTD |
| G |
PARP1 |
poly (ADP-ribose) polymerase 1 |
|
decreases expression |
EXP |
1 |
226,548,392 |
226,595,801 |
RGD:6480464 |
CTD |
| G |
PARP1 |
poly (ADP-ribose) polymerase 1 |
|
decreases expression |
EXP |
1 |
226,548,392 |
226,595,801 |
RGD:6480464 |
CTD |
| G |
PARP1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
EXP |
1 |
226,548,392 |
226,595,801 |
RGD:6480464 |
CTD |
| G |
PARP1 |
poly (ADP-ribose) polymerase 1 |
|
increases methylation |
EXP |
1 |
226,548,392 |
226,595,801 |
RGD:6480464 |
CTD |
| G |
PARP14 |
poly (ADP-ribose) polymerase family, member 14 |
|
decreases expression |
ISO |
3 |
122,399,672 |
122,449,687 |
RGD:6480464 |
CTD |
| G |
PATZ1 |
POZ (BTB) and AT hook containing zinc finger 1 |
|
decreases expression |
ISO |
22 |
31,721,790 |
31,742,249 |
RGD:6480464 |
CTD |
| G |
PAX6 |
paired box 6 |
|
decreases expression |
ISO |
11 |
31,806,340 |
31,839,509 |
RGD:6480464 |
CTD |
| G |
PCGF6 |
polycomb group ring finger 6 |
|
decreases expression |
ISO |
10 |
105,062,553 |
105,110,891 |
RGD:6480464 |
CTD |
| G |
PCM1 |
pericentriolar material 1 |
|
decreases expression |
ISO |
8 |
17,780,366 |
17,887,457 |
RGD:6480464 |
CTD |
| G |
PCYOX1 |
prenylcysteine oxidase 1 |
|
decreases expression |
ISO |
2 |
70,485,231 |
70,508,317 |
RGD:6480464 |
CTD |
| G |
PDE4B |
phosphodiesterase 4B, cAMP-specific |
|
decreases expression |
ISO |
1 |
66,258,193 |
66,840,262 |
RGD:6480464 |
CTD |
| G |
PDE7A |
phosphodiesterase 7A |
|
decreases expression |
ISO |
8 |
66,626,569 |
66,753,969 |
RGD:6480464 |
CTD |
| G |
PDGFB |
platelet-derived growth factor beta polypeptide |
|
increases expression |
ISO |
22 |
39,619,685 |
39,640,957 |
RGD:6480464 |
CTD |
| G |
PDIK1L |
PDLIM1 interacting kinase 1 like |
|
decreases expression |
ISO |
1 |
26,437,656 |
26,452,039 |
RGD:6480464 |
CTD |
| G |
PDLIM7 |
PDZ and LIM domain 7 (enigma) |
|
increases expression |
ISO |
5 |
176,910,395 |
176,924,602 |
RGD:6480464 |
CTD |
| G |
PER1 |
period circadian clock 1 |
|
increases expression |
ISO |
17 |
8,043,788 |
8,055,753 |
RGD:6480464 |
CTD |
| G |
PHF17 |
PHD finger protein 17 |
|
decreases expression |
ISO |
4 |
129,730,779 |
129,796,379 |
RGD:6480464 |
CTD |
| G |
PHLDA1 |
pleckstrin homology-like domain, family A, member 1 |
|
increases expression |
ISO |
12 |
76,419,227 |
76,425,556 |
RGD:6480464 |
CTD |
| G |
PIAS1 |
protein inhibitor of activated STAT, 1 |
|
decreases expression |
ISO |
15 |
68,346,572 |
68,480,413 |
RGD:6480464 |
CTD |
| G |
PIGH |
phosphatidylinositol glycan anchor biosynthesis, class H |
|
decreases expression |
ISO |
14 |
68,056,023 |
68,067,017 |
RGD:6480464 |
CTD |
| G |
PIK3CG |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
|
decreases expression |
ISO |
7 |
106,505,924 |
106,547,592 |
RGD:6480464 |
CTD |
| G |
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
|
decreases expression |
ISO |
5 |
67,511,584 |
67,597,649 |
RGD:6480464 |
CTD |
| G |
PIM1 |
pim-1 oncogene |
|
increases expression |
ISO |
6 |
37,137,922 |
37,143,204 |
RGD:6480464 |
CTD |
| G |
PIM3 |
pim-3 oncogene |
|
increases expression |
ISO |
22 |
50,354,143 |
50,357,720 |
RGD:6480464 |
CTD |
| G |
PIP5K1B |
phosphatidylinositol-4-phosphate 5-kinase, type I, beta |
|
increases expression |
ISO |
9 |
71,320,616 |
71,624,091 |
RGD:6480464 |
CTD |
| G |
PJA1 |
praja ring finger 1, E3 ubiquitin protein ligase |
|
decreases expression |
ISO |
X |
68,380,581 |
68,385,365 |
RGD:6480464 |
CTD |
| G |
PLA2G15 |
phospholipase A2, group XV |
|
decreases expression |
ISO |
16 |
68,279,247 |
68,294,961 |
RGD:6480464 |
CTD |
| G |
PLAU |
plasminogen activator, urokinase |
|
increases expression |
ISO |
10 |
75,670,862 |
75,677,259 |
RGD:6480464 |
CTD |
| G |
PLAUR |
plasminogen activator, urokinase receptor |
|
increases expression |
ISO |
19 |
44,150,247 |
44,174,498 |
RGD:6480464 |
CTD |
| G |
PLEK |
pleckstrin |
|
increases expression |
ISO |
2 |
68,592,322 |
68,624,585 |
RGD:6480464 |
CTD |
| G |
PLK2 |
polo-like kinase 2 |
|
increases expression |
ISO |
5 |
57,749,809 |
57,755,966 |
RGD:6480464 |
CTD |
| G |
PLK3 |
polo-like kinase 3 |
|
increases expression |
ISO |
1 |
45,266,036 |
45,271,667 |
RGD:6480464 |
CTD |
| G |
PLXNC1 |
plexin C1 |
|
decreases expression |
ISO |
12 |
94,542,499 |
94,701,451 |
RGD:6480464 |
CTD |
| G |
PMAIP1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
|
increases expression |
ISO |
18 |
57,567,192 |
57,571,538 |
RGD:6480464 |
CTD |
| G |
PMP22 |
peripheral myelin protein 22 |
|
increases expression |
ISO |
17 |
15,133,096 |
15,168,644 |
RGD:6480464 |
CTD |
| G |
PNRC1 |
proline-rich nuclear receptor coactivator 1 |
|
increases expression |
ISO |
6 |
89,790,429 |
89,794,879 |
RGD:6480464 |
CTD |
| G |
PNRC2 |
proline-rich nuclear receptor coactivator 2 |
|
decreases expression |
ISO |
1 |
24,286,301 |
24,289,952 |
RGD:6480464 |
CTD |
| G |
POLI |
polymerase (DNA directed) iota |
|
decreases expression |
ISO |
18 |
51,795,849 |
51,824,604 |
RGD:6480464 |
CTD |
| G |
POLR3G |
polymerase (RNA) III (DNA directed) polypeptide G (32kD) |
|
decreases expression |
ISO |
5 |
89,770,681 |
89,810,369 |
RGD:6480464 |
CTD |
| G |
POLR3K |
polymerase (RNA) III (DNA directed) polypeptide K, 12.3 kDa |
|
decreases expression |
ISO |
16 |
96,979 |
103,632 |
RGD:6480464 |
CTD |
| G |
POLRMT |
polymerase (RNA) mitochondrial (DNA directed) |
|
decreases expression |
ISO |
19 |
617,223 |
633,568 |
RGD:6480464 |
CTD |
| G |
PON1 |
paraoxonase 1 |
|
decreases expression |
EXP |
7 |
94,927,669 |
94,953,884 |
RGD:6480464 |
CTD |
| G |
PON2 |
paraoxonase 2 |
|
decreases expression |
ISO |
7 |
95,034,174 |
95,064,384 |
RGD:6480464 |
CTD |
| G |
PPARGC1B |
peroxisome proliferator-activated receptor gamma, coactivator 1 beta |
|
decreases expression |
ISO |
5 |
149,109,815 |
149,234,585 |
RGD:6480464 |
CTD |
| G |
PPCS |
phosphopantothenoylcysteine synthetase |
|
decreases expression |
ISO |
1 |
42,922,173 |
42,926,086 |
RGD:6480464 |
CTD |
| G |
PPP1R10 |
protein phosphatase 1, regulatory subunit 10 |
|
increases expression |
ISO |
6 |
30,568,177 |
30,585,084 |
RGD:6480464 |
CTD |
| G |
PPP1R15A |
protein phosphatase 1, regulatory subunit 15A |
|
increases expression |
ISO |
19 |
49,375,649 |
49,379,319 |
RGD:6480464 |
CTD |
| G |
PPP3R1 |
protein phosphatase 3, regulatory subunit B, alpha |
|
decreases expression |
ISO |
2 |
68,405,989 |
68,479,651 |
RGD:6480464 |
CTD |
| G |
PRKAG2 |
protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
|
decreases expression |
ISO |
7 |
151,253,200 |
151,574,316 |
RGD:6480464 |
CTD |
| G |
PRKAR1B |
protein kinase, cAMP-dependent, regulatory, type I, beta |
|
decreases expression |
ISO |
7 |
588,834 |
767,313 |
RGD:6480464 |
CTD |
| G |
PROCR |
protein C receptor, endothelial |
|
increases expression |
ISO |
20 |
33,759,774 |
33,765,165 |
RGD:6480464 |
CTD |
| G |
PROS1 |
protein S (alpha) |
|
decreases expression |
ISO |
3 |
93,591,881 |
93,692,934 |
RGD:6480464 |
CTD |
| G |
PRPF39 |
PRP39 pre-mRNA processing factor 39 homolog (S. cerevisiae) |
|
decreases expression |
ISO |
14 |
45,553,302 |
45,584,804 |
RGD:6480464 |
CTD |
| G |
PRR12 |
proline rich 12 |
|
decreases expression |
ISO |
19 |
50,094,912 |
50,129,696 |
RGD:6480464 |
CTD |
| G |
PRSS35 |
protease, serine, 35 |
|
decreases expression |
ISO |
6 |
84,222,194 |
84,235,423 |
RGD:6480464 |
CTD |
| G |
PSEN1 |
presenilin 1 |
|
increases expression |
ISO |
14 |
73,603,143 |
73,690,399 |
RGD:6480464 |
CTD |
| G |
PSMC6 |
proteasome (prosome, macropain) 26S subunit, ATPase, 6 |
|
decreases expression |
ISO |
14 |
53,173,896 |
53,194,716 |
RGD:6480464 |
CTD |
| G |
PSMF1 |
proteasome (prosome, macropain) inhibitor subunit 1 (PI31) |
|
decreases expression |
ISO |
20 |
1,093,906 |
1,148,426 |
RGD:6480464 |
CTD |
| G |
PTAFR |
platelet-activating factor receptor |
|
increases expression |
ISO |
1 |
28,473,677 |
28,520,447 |
RGD:6480464 |
CTD |
| G |
PTCH1 |
patched 1 |
|
decreases expression |
ISO |
9 |
98,205,264 |
98,279,247 |
RGD:6480464 |
CTD |
| G |
PTGS1 |
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
|
decreases expression |
ISO |
9 |
125,132,809 |
125,157,982 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
increases expression |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
increases expression |
EXP |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
increases expression |
EXP |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
increases expression |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTPLAD2 |
protein tyrosine phosphatase-like A domain containing 2 |
|
decreases expression |
ISO |
9 |
21,006,365 |
21,031,635 |
RGD:6480464 |
CTD |
| G |
PTPRO |
protein tyrosine phosphatase, receptor type, O |
|
decreases expression |
ISO |
12 |
15,475,191 |
15,751,265 |
RGD:6480464 |
CTD |
| G |
PURA |
purine-rich element binding protein A |
|
decreases expression |
ISO |
5 |
139,493,708 |
139,499,001 |
RGD:6480464 |
CTD |
| G |
PUS3 |
pseudouridylate synthase 3 |
|
decreases expression |
ISO |
11 |
125,763,380 |
125,773,116 |
RGD:6480464 |
CTD |
| G |
PVR |
poliovirus receptor |
|
increases expression |
ISO |
19 |
45,147,098 |
45,169,429 |
RGD:6480464 |
CTD |
| G |
PYCARD |
PYD and CARD domain containing |
|
multiple interactions |
ISO |
16 |
31,212,807 |
31,214,097 |
RGD:6480464 |
CTD |
| G |
QSER1 |
glutamine and serine rich 1 |
|
decreases expression |
ISO |
11 |
32,914,792 |
33,001,816 |
RGD:6480464 |
CTD |
| G |
RAB11FIP5 |
RAB11 family interacting protein 5 (class I) |
|
decreases expression |
ISO |
2 |
73,300,510 |
73,340,146 |
RGD:6480464 |
CTD |
| G |
RAB14 |
RAB14, member RAS oncogene family |
|
decreases expression |
ISO |
9 |
123,940,415 |
123,964,365 |
RGD:6480464 |
CTD |
| G |
RAB20 |
RAB20, member RAS oncogene family |
|
increases expression |
ISO |
13 |
111,175,413 |
111,214,071 |
RGD:6480464 |
CTD |
| G |
RAB3IL1 |
RAB3A interacting protein (rabin3)-like 1 |
|
decreases expression |
ISO |
11 |
61,664,773 |
61,684,997 |
RGD:6480464 |
CTD |
| G |
RAD1 |
RAD1 homolog (S. pombe) |
|
decreases expression |
ISO |
5 |
34,905,365 |
34,915,780 |
RGD:6480464 |
CTD |
| G |
RAD52 |
RAD52 homolog (S. cerevisiae) |
|
decreases expression |
ISO |
12 |
1,021,255 |
1,058,863 |
RGD:6480464 |
CTD |
| G |
RAD54L |
RAD54-like (S. cerevisiae) |
|
decreases expression |
ISO |
1 |
46,713,367 |
46,744,145 |
RGD:6480464 |
CTD |
| G |
RAMP2 |
receptor (G protein-coupled) activity modifying protein 2 |
|
increases expression |
ISO |
17 |
40,913,212 |
40,915,059 |
RGD:6480464 |
CTD |
| G |
RASSF2 |
Ras association (RalGDS/AF-6) domain family member 2 |
|
decreases expression |
ISO |
20 |
4,760,669 |
4,804,291 |
RGD:6480464 |
CTD |
| G |
RASSF3 |
Ras association (RalGDS/AF-6) domain family member 3 |
|
decreases expression |
ISO |
12 |
65,004,293 |
65,091,347 |
RGD:6480464 |
CTD |
| G |
RBBP6 |
retinoblastoma binding protein 6 |
|
decreases expression |
ISO |
16 |
24,550,908 |
24,584,184 |
RGD:6480464 |
CTD |
| G |
RBL2 |
retinoblastoma-like 2 (p130) |
|
decreases expression |
ISO |
16 |
53,468,351 |
53,525,560 |
RGD:6480464 |
CTD |
| G |
RBM39 |
RNA binding motif protein 39 |
|
decreases expression |
ISO |
20 |
34,291,531 |
34,330,258 |
RGD:6480464 |
CTD |
| G |
RBM39 |
RNA binding motif protein 39 |
|
increases expression |
ISO |
20 |
34,291,531 |
34,330,258 |
RGD:6480464 |
CTD |
| G |
RBMX |
RNA binding motif protein, X-linked |
|
decreases expression |
ISO |
X |
135,951,353 |
135,962,939 |
RGD:6480464 |
CTD |
| G |
RCAN1 |
regulator of calcineurin 1 |
|
increases expression |
ISO |
21 |
35,888,782 |
35,987,382 |
RGD:6480464 |
CTD |
| G |
RCAN3 |
RCAN family member 3 |
|
decreases expression |
ISO |
1 |
24,828,841 |
24,863,510 |
RGD:6480464 |
CTD |
| G |
RDH11 |
retinol dehydrogenase 11 (all-trans/9-cis/11-cis) |
|
increases expression |
ISO |
14 |
68,143,517 |
68,162,510 |
RGD:6480464 |
CTD |
| G |
RDH14 |
retinol dehydrogenase 14 (all-trans/9-cis/11-cis) |
|
decreases expression |
ISO |
2 |
18,735,989 |
18,741,959 |
RGD:6480464 |
CTD |
| G |
REEP3 |
receptor accessory protein 3 |
|
decreases expression |
ISO |
10 |
65,281,123 |
65,384,883 |
RGD:6480464 |
CTD |
| G |
REL |
v-rel reticuloendotheliosis viral oncogene homolog (avian) |
|
increases expression |
ISO |
2 |
61,108,752 |
61,150,178 |
RGD:6480464 |
CTD |
| G |
RERE |
arginine-glutamic acid dipeptide (RE) repeats |
|
decreases expression |
ISO |
1 |
8,412,464 |
8,877,699 |
RGD:6480464 |
CTD |
| G |
RFX5 |
regulatory factor X, 5 (influences HLA class II expression) |
|
decreases expression |
ISO |
1 |
151,313,116 |
151,319,769 |
RGD:6480464 |
CTD |
| G |
RGS1 |
regulator of G-protein signaling 1 |
|
increases expression |
ISO |
1 |
192,544,857 |
192,549,159 |
RGD:6480464 |
CTD |
| G |
RGS16 |
regulator of G-protein signaling 16 |
|
increases expression |
ISO |
1 |
182,567,758 |
182,573,548 |
RGD:6480464 |
CTD |
| G |
RGS2 |
regulator of G-protein signaling 2, 24kDa |
|
increases expression |
ISO |
1 |
192,778,169 |
192,781,407 |
RGD:6480464 |
CTD |
| G |
RHOB |
ras homolog family member B |
|
increases expression |
ISO |
2 |
20,646,835 |
20,649,201 |
RGD:6480464 |
CTD |
| G |
RHOC |
ras homolog family member C |
|
increases expression |
ISO |
1 |
113,243,749 |
113,250,025 |
RGD:6480464 |
CTD |
| G |
RIF1 |
RAP1 interacting factor homolog (yeast) |
|
decreases expression |
ISO |
2 |
152,266,397 |
152,333,860 |
RGD:6480464 |
CTD |
| G |
RIN2 |
Ras and Rab interactor 2 |
|
decreases expression |
ISO |
20 |
19,867,165 |
19,983,103 |
RGD:6480464 |
CTD |
| G |
RIT1 |
Ras-like without CAAX 1 |
|
decreases expression |
ISO |
1 |
155,867,599 |
155,881,193 |
RGD:6480464 |
CTD |
| G |
RMDN1 |
regulator of microtubule dynamics 1 |
|
decreases expression |
ISO |
8 |
87,484,578 |
87,521,009 |
RGD:6480464 |
CTD |
| G |
RNASEL |
ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent) |
|
decreases expression |
ISO |
1 |
182,542,769 |
182,558,394 |
RGD:6480464 |
CTD |
| G |
RPL22 |
ribosomal protein L22 |
|
decreases expression |
ISO |
1 |
6,245,080 |
6,259,679 |
RGD:6480464 |
CTD |
| G |
RPL30 |
ribosomal protein L30 |
|
decreases expression |
ISO |
8 |
99,053,938 |
99,057,818 |
RGD:6480464 |
CTD |
| G |
RPL41 |
ribosomal protein L41 |
|
decreases expression |
ISO |
12 |
56,510,374 |
56,511,616 |
RGD:6480464 |
CTD |
| G |
RREB1 |
ras responsive element binding protein 1 |
|
decreases expression |
ISO |
6 |
7,107,830 |
7,252,213 |
RGD:6480464 |
CTD |
| G |
RSRC1 |
arginine/serine-rich coiled-coil 1 |
|
decreases expression |
ISO |
3 |
157,827,892 |
158,262,582 |
RGD:6480464 |
CTD |
| G |
RUNX1 |
runt-related transcription factor 1 |
|
increases expression |
ISO |
21 |
36,160,098 |
36,421,595 |
RGD:6480464 |
CTD |
| G |
RUSC2 |
RUN and SH3 domain containing 2 |
|
increases expression |
ISO |
9 |
35,490,007 |
35,561,895 |
RGD:6480464 |
CTD |
| G |
RWDD3 |
RWD domain containing 3 |
|
decreases expression |
ISO |
1 |
95,699,711 |
95,712,781 |
RGD:6480464 |
CTD |
| G |
RYBP |
RING1 and YY1 binding protein |
|
increases expression |
ISO |
3 |
72,423,744 |
72,495,774 |
RGD:6480464 |
CTD |
| G |
S100A8 |
S100 calcium binding protein A8 |
|
increases expression |
ISO |
1 |
153,362,508 |
153,363,664 |
RGD:6480464 |
CTD |
| G |
S100A9 |
S100 calcium binding protein A9 |
|
increases expression |
ISO |
1 |
153,330,330 |
153,333,503 |
RGD:6480464 |
CTD |
| G |
S1PR1 |
sphingosine-1-phosphate receptor 1 |
|
decreases expression |
ISO |
1 |
101,702,305 |
101,707,076 |
RGD:6480464 |
CTD |
| G |
SAT1 |
spermidine/spermine N1-acetyltransferase 1 |
|
increases expression |
ISO |
X |
23,801,275 |
23,804,327 |
RGD:6480464 |
CTD |
| G |
SCD |
stearoyl-CoA desaturase (delta-9-desaturase) |
|
decreases expression |
ISO |
10 |
102,106,772 |
102,124,588 |
RGD:6480464 |
CTD |
| G |
SDC4 |
syndecan 4 |
|
increases expression |
ISO |
20 |
43,953,928 |
43,977,064 |
RGD:6480464 |
CTD |
| G |
SDHAF1 |
succinate dehydrogenase complex assembly factor 1 |
|
decreases expression |
ISO |
19 |
36,486,090 |
36,487,220 |
RGD:6480464 |
CTD |
| G |
SEC63 |
SEC63 homolog (S. cerevisiae) |
|
decreases expression |
ISO |
6 |
108,188,960 |
108,279,482 |
RGD:6480464 |
CTD |
| G |
SEMA4A |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
|
decreases expression |
ISO |
1 |
156,119,735 |
156,147,542 |
RGD:6480464 |
CTD |
| G |
SERPINB2 |
serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
|
multiple interactions |
ISO |
18 |
61,554,939 |
61,571,124 |
RGD:6480464 |
CTD |
| G |
SERPINE1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
increases expression |
ISO |
7 |
100,770,370 |
100,782,547 |
RGD:6480464 |
CTD |
| G |
SERTAD1 |
SERTA domain containing 1 |
|
increases expression |
ISO |
19 |
40,928,408 |
40,931,932 |
RGD:6480464 |
CTD |
| G |
SERTAD2 |
SERTA domain containing 2 |
|
increases expression |
ISO |
2 |
64,858,755 |
64,881,046 |
RGD:6480464 |
CTD |
| G |
SESN1 |
sestrin 1 |
|
decreases expression |
ISO |
6 |
109,307,640 |
109,415,708 |
RGD:6480464 |
CTD |
| G |
SESN2 |
sestrin 2 |
|
increases expression |
ISO |
1 |
28,585,963 |
28,609,002 |
RGD:6480464 |
CTD |
| G |
SETD1A |
SET domain containing 1A |
|
decreases expression |
ISO |
16 |
30,968,615 |
30,995,981 |
RGD:6480464 |
CTD |
| G |
SETDB1 |
SET domain, bifurcated 1 |
|
decreases expression |
ISO |
1 |
150,898,815 |
150,937,220 |
RGD:6480464 |
CTD |
| G |
SFI1 |
Sfi1 homolog, spindle assembly associated (yeast) |
|
decreases expression |
ISO |
22 |
31,892,125 |
32,014,537 |
RGD:6480464 |
CTD |
| G |
SFPQ |
splicing factor proline/glutamine-rich |
|
decreases expression |
ISO |
1 |
35,649,201 |
35,658,743 |
RGD:6480464 |
CTD |
| G |
SGPP1 |
sphingosine-1-phosphate phosphatase 1 |
|
decreases expression |
ISO |
14 |
64,150,934 |
64,194,756 |
RGD:6480464 |
CTD |
| G |
SH3BP5 |
SH3-domain binding protein 5 (BTK-associated) |
|
decreases expression |
ISO |
3 |
15,295,860 |
15,382,901 |
RGD:6480464 |
CTD |
| G |
SHPRH |
SNF2 histone linker PHD RING helicase, E3 ubiquitin protein ligase |
|
decreases expression |
ISO |
6 |
146,205,943 |
146,285,233 |
RGD:6480464 |
CTD |
| G |
SIAE |
sialic acid acetylesterase |
|
decreases expression |
ISO |
11 |
124,505,685 |
124,546,199 |
RGD:6480464 |
CTD |
| G |
SIAH2 |
siah E3 ubiquitin protein ligase 2 |
|
increases expression |
ISO |
3 |
150,458,910 |
150,481,263 |
RGD:6480464 |
CTD |
| G |
SKIL |
SKI-like oncogene |
|
increases expression |
ISO |
3 |
170,075,473 |
170,114,637 |
RGD:6480464 |
CTD |
| G |
SLA |
Src-like-adaptor |
|
decreases expression |
ISO |
8 |
134,048,973 |
134,115,310 |
RGD:6480464 |
CTD |
| G |
SLC15A3 |
solute carrier family 15, member 3 |
|
increases expression |
ISO |
11 |
60,704,555 |
60,719,257 |
RGD:6480464 |
CTD |
| G |
SLC16A7 |
solute carrier family 16, member 7 (monocarboxylic acid transporter 2) |
|
decreases expression |
ISO |
12 |
59,989,821 |
60,183,636 |
RGD:6480464 |
CTD |
| G |
SLC20A1 |
solute carrier family 20 (phosphate transporter), member 1 |
|
increases expression |
ISO |
2 |
113,403,434 |
113,421,402 |
RGD:6480464 |
CTD |
| G |
SLC25A25 |
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 25 |
|
increases expression |
ISO |
9 |
130,830,479 |
130,871,537 |
RGD:6480464 |
CTD |
| G |
SLC25A37 |
solute carrier family 25 (mitochondrial iron transporter), member 37 |
|
decreases expression |
ISO |
8 |
23,386,363 |
23,430,063 |
RGD:6480464 |
CTD |
| G |
SLC25A51 |
solute carrier family 25, member 51 |
|
decreases expression |
ISO |
9 |
37,877,572 |
37,904,350 |
RGD:6480464 |
CTD |
| G |
SLC30A1 |
solute carrier family 30 (zinc transporter), member 1 |
|
increases expression |
ISO |
1 |
211,748,381 |
211,752,099 |
RGD:6480464 |
CTD |
| G |
SLC40A1 |
solute carrier family 40 (iron-regulated transporter), member 1 |
|
increases expression |
ISO |
2 |
190,425,316 |
190,445,537 |
RGD:6480464 |
CTD |
| G |
SLC5A3 |
solute carrier family 5 (sodium/myo-inositol cotransporter), member 3 |
|
increases expression |
ISO |
21 |
35,445,870 |
35,478,561 |
RGD:6480464 |
CTD |
| G |
SLC7A11 |
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
|
increases expression |
ISO |
4 |
139,085,248 |
139,163,503 |
RGD:6480464 |
CTD |
| G |
SLFN12L |
schlafen family member 12-like |
|
increases expression |
ISO |
17 |
33,801,942 |
33,814,758 |
RGD:6480464 |
CTD |
| G |
SMC6 |
structural maintenance of chromosomes 6 |
|
decreases expression |
ISO |
2 |
17,845,079 |
17,935,096 |
RGD:6480464 |
CTD |
| G |
SNAPC3 |
small nuclear RNA activating complex, polypeptide 3, 50kDa |
|
decreases expression |
ISO |
9 |
15,422,782 |
15,461,627 |
RGD:6480464 |
CTD |
| G |
SNX5 |
sorting nexin 5 |
|
decreases expression |
ISO |
20 |
17,922,244 |
17,949,490 |
RGD:6480464 |
CTD |
| G |
SOCS3 |
suppressor of cytokine signaling 3 |
|
decreases expression |
ISO |
17 |
76,352,859 |
76,356,158 |
RGD:6480464 |
CTD |
| G |
SOCS3 |
suppressor of cytokine signaling 3 |
|
increases expression |
ISO |
17 |
76,352,859 |
76,356,158 |
RGD:6480464 |
CTD |
| G |
SOCS3 |
suppressor of cytokine signaling 3 |
|
multiple interactions |
ISO |
17 |
76,352,859 |
76,356,158 |
RGD:6480464 |
CTD |
| G |
SOD1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
ISO |
21 |
33,031,935 |
33,041,244 |
RGD:6480464 |
CTD |
| G |
SOD2 |
superoxide dismutase 2, mitochondrial |
|
increases expression |
ISO |
6 |
160,100,148 |
160,114,353 |
RGD:6480464 |
CTD |
| G |
SOD2 |
superoxide dismutase 2, mitochondrial |
|
increases expression |
ISO |
6 |
160,100,148 |
160,114,353 |
RGD:6480464 |
CTD |
| G |
SORBS1 |
sorbin and SH3 domain containing 1 |
|
decreases expression |
ISO |
10 |
97,071,530 |
97,321,171 |
RGD:6480464 |
CTD |
| G |
SPAST |
spastin |
|
decreases expression |
ISO |
2 |
32,288,680 |
32,382,706 |
RGD:6480464 |
CTD |
| G |
SPATA13 |
spermatogenesis associated 13 |
|
decreases expression |
ISO |
13 |
24,734,861 |
24,881,212 |
RGD:6480464 |
CTD |
| G |
SPP1 |
secreted phosphoprotein 1 |
|
decreases expression |
EXP |
4 |
88,896,802 |
88,904,563 |
RGD:6480464 |
CTD |
| G |
SQSTM1 |
sequestosome 1 |
|
increases expression |
ISO |
5 |
179,233,388 |
179,265,078 |
RGD:6480464 |
CTD |
| G |
SRXN1 |
sulfiredoxin 1 |
|
increases expression |
ISO |
20 |
627,259 |
633,890 |
RGD:6480464 |
CTD |
| G |
ST6GAL1 |
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 |
|
decreases expression |
ISO |
3 |
186,648,315 |
186,796,341 |
RGD:6480464 |
CTD |
| G |
ST8SIA4 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 |
|
decreases expression |
ISO |
5 |
100,142,639 |
100,238,987 |
RGD:6480464 |
CTD |
| G |
STAMBP |
STAM binding protein |
|
decreases expression |
ISO |
2 |
74,056,043 |
74,094,295 |
RGD:6480464 |
CTD |
| G |
STARD5 |
StAR-related lipid transfer (START) domain containing 5 |
|
decreases expression |
ISO |
15 |
81,605,007 |
81,616,524 |
RGD:6480464 |
CTD |
| G |
STAT1 |
signal transducer and activator of transcription 1, 91kDa |
|
multiple interactions |
ISO |
2 |
191,833,762 |
191,878,976 |
RGD:6480464 |
CTD |
| G |
STAT2 |
signal transducer and activator of transcription 2, 113kDa |
|
multiple interactions |
ISO |
12 |
56,735,381 |
56,754,037 |
RGD:6480464 |
CTD |
| G |
STAT3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
multiple interactions |
ISO |
17 |
40,465,343 |
40,540,513 |
RGD:6480464 |
CTD |
| G |
STAT3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
multiple interactions |
ISO |
17 |
40,465,343 |
40,540,513 |
RGD:6480464 |
CTD |
| G |
STAT3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
increases expression |
ISO |
17 |
40,465,343 |
40,540,513 |
RGD:6480464 |
CTD |
| G |
STAT5A |
signal transducer and activator of transcription 5A |
|
multiple interactions |
ISO |
17 |
40,439,565 |
40,463,961 |
RGD:6480464 |
CTD |
| G |
STX17 |
syntaxin 17 |
|
decreases expression |
ISO |
9 |
102,668,915 |
102,736,818 |
RGD:6480464 |
CTD |
| G |
SUPT20H |
suppressor of Ty 20 homolog (S. cerevisiae) |
|
decreases expression |
ISO |
13 |
37,583,449 |
37,633,850 |
RGD:6480464 |
CTD |
| G |
SYK |
spleen tyrosine kinase |
|
decreases expression |
ISO |
9 |
93,564,012 |
93,660,842 |
RGD:6480464 |
CTD |
| G |
TAF1D |
TATA box binding protein (TBP)-associated factor, RNA polymerase I, D, 41kDa |
|
decreases expression |
ISO |
11 |
93,469,095 |
93,474,703 |
RGD:6480464 |
CTD |
| G |
TAF4 |
TAF4 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 135kDa |
|
decreases expression |
ISO |
20 |
60,549,854 |
60,640,866 |
RGD:6480464 |
CTD |
| G |
TANK |
TRAF family member-associated NFKB activator |
|
decreases expression |
EXP |
2 |
161,993,466 |
162,092,683 |
RGD:6480464 |
CTD |
| G |
TARDBP |
TAR DNA binding protein |
|
decreases expression |
ISO |
1 |
11,072,679 |
11,085,549 |
RGD:6480464 |
CTD |
| G |
TCF25 |
transcription factor 25 (basic helix-loop-helix) |
|
increases expression |
ISO |
16 |
89,939,994 |
89,977,792 |
RGD:6480464 |
CTD |
| G |
TCF4 |
transcription factor 4 |
|
decreases expression |
ISO |
18 |
52,889,562 |
53,303,188 |
RGD:6480464 |
CTD |
| G |
TCTA |
T-cell leukemia translocation altered |
|
decreases expression |
ISO |
3 |
49,449,639 |
49,453,909 |
RGD:6480464 |
CTD |
| G |
TCTE3 |
t-complex-associated-testis-expressed 3 |
|
decreases expression |
ISO |
6 |
170,140,215 |
170,151,638 |
RGD:6480464 |
CTD |
| G |
TFAP4 |
transcription factor AP-4 (activating enhancer binding protein 4) |
|
decreases expression |
ISO |
16 |
4,307,187 |
4,323,001 |
RGD:6480464 |
CTD |
| G |
TGFB1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
19 |
41,836,812 |
41,859,831 |
RGD:6480464 |
CTD |
| G |
TGFB1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
19 |
41,836,812 |
41,859,831 |
RGD:6480464 |
CTD |
| G |
TGFB1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
19 |
41,836,812 |
41,859,831 |
RGD:6480464 |
CTD |
| G |
TGFB1 |
transforming growth factor, beta 1 |
|
increases expression |
ISO |
19 |
41,836,812 |
41,859,831 |
RGD:6480464 |
CTD |
| G |
TGFB1 |
transforming growth factor, beta 1 |
|
increases expression |
ISO |
19 |
41,836,812 |
41,859,831 |
RGD:6480464 |
CTD |
| G |
TGIF1 |
TGFB-induced factor homeobox 1 |
|
increases expression |
ISO |
18 |
3,412,072 |
3,458,409 |
RGD:6480464 |
CTD |
| G |
THAP11 |
THAP domain containing 11 |
|
decreases expression |
ISO |
16 |
67,876,213 |
67,878,098 |
RGD:6480464 |
CTD |
| G |
TIA1 |
TIA1 cytotoxic granule-associated RNA binding protein |
|
decreases expression |
ISO |
2 |
70,436,576 |
70,475,779 |
RGD:6480464 |
CTD |
| G |
TICAM1 |
toll-like receptor adaptor molecule 1 |
|
multiple interactions |
ISO |
19 |
4,815,936 |
4,831,754 |
RGD:6480464 |
CTD |
| G |
TIFA |
TRAF-interacting protein with forkhead-associated domain |
|
decreases expression |
ISO |
4 |
113,196,782 |
113,207,059 |
RGD:6480464 |
CTD |
| G |
TIMM9 |
translocase of inner mitochondrial membrane 9 homolog (yeast) |
|
decreases expression |
ISO |
14 |
58,875,370 |
58,894,232 |
RGD:6480464 |
CTD |
| G |
TIPARP |
TCDD-inducible poly(ADP-ribose) polymerase |
|
increases expression |
ISO |
3 |
156,392,205 |
156,424,559 |
RGD:6480464 |
CTD |
| G |
TLCD1 |
TLC domain containing 1 |
|
decreases expression |
ISO |
17 |
27,051,366 |
27,053,949 |
RGD:6480464 |
CTD |
| G |
TLR2 |
toll-like receptor 2 |
|
increases expression |
ISO |
4 |
154,605,441 |
154,627,243 |
RGD:6480464 |
CTD |
| G |
TLR4 |
toll-like receptor 4 |
|
decreases expression |
ISO |
9 |
120,466,453 |
120,479,769 |
RGD:6480464 |
CTD |
| G |
TM9SF2 |
transmembrane 9 superfamily member 2 |
|
decreases expression |
ISO |
13 |
100,153,728 |
100,215,276 |
RGD:6480464 |
CTD |
| G |
TMEM123 |
transmembrane protein 123 |
|
decreases expression |
ISO |
11 |
102,267,056 |
102,323,775 |
RGD:6480464 |
CTD |
| G |
TMEM186 |
transmembrane protein 186 |
|
decreases expression |
ISO |
16 |
8,889,037 |
8,891,505 |
RGD:6480464 |
CTD |
| G |
TMEM206 |
transmembrane protein 206 |
|
decreases expression |
ISO |
1 |
212,537,816 |
212,588,267 |
RGD:6480464 |
CTD |
| G |
TMEM218 |
transmembrane protein 218 |
|
decreases expression |
ISO |
11 |
124,964,266 |
124,981,659 |
RGD:6480464 |
CTD |
| G |
TMLHE |
trimethyllysine hydroxylase, epsilon |
|
increases expression |
ISO |
X |
154,718,672 |
154,842,622 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
increases expression |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
increases expression |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
increases secretion |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
increases expression |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
increases expression |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
increases expression |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
increases expression |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
increases secretion |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
increases expression |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
increases secretion |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNFAIP8 |
tumor necrosis factor, alpha-induced protein 8 |
|
decreases expression |
ISO |
5 |
118,604,418 |
118,730,294 |
RGD:6480464 |
CTD |
| G |
TNFAIP8 |
tumor necrosis factor, alpha-induced protein 8 |
|
decreases expression |
ISO |
5 |
118,604,418 |
118,730,294 |
RGD:6480464 |
CTD |
| G |
TNFRSF12A |
tumor necrosis factor receptor superfamily, member 12A |
|
increases expression |
ISO |
16 |
3,070,313 |
3,072,384 |
RGD:6480464 |
CTD |
| G |
TNFSF9 |
tumor necrosis factor (ligand) superfamily, member 9 |
|
increases expression |
ISO |
19 |
6,531,010 |
6,535,939 |
RGD:6480464 |
CTD |
| G |
TNRC6A |
trinucleotide repeat containing 6A |
|
decreases expression |
ISO |
16 |
24,741,049 |
24,837,548 |
RGD:6480464 |
CTD |
| G |
TOLLIP |
toll interacting protein |
|
increases expression |
EXP |
11 |
1,295,598 |
1,330,892 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
increases expression |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
multiple interactions |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
increases expression |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
increases expression |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
multiple interactions |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
increases expression |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TRAF1 |
TNF receptor-associated factor 1 |
|
increases expression |
ISO |
9 |
123,664,671 |
123,691,451 |
RGD:6480464 |
CTD |
| G |
TRAPPC5 |
trafficking protein particle complex 5 |
|
decreases expression |
ISO |
19 |
7,745,707 |
7,747,748 |
RGD:6480464 |
CTD |
| G |
TREM1 |
triggering receptor expressed on myeloid cells 1 |
|
increases expression |
ISO |
6 |
41,242,999 |
41,254,457 |
RGD:6480464 |
CTD |
| G |
TREX1 |
three prime repair exonuclease 1 |
|
decreases expression |
ISO |
3 |
48,506,919 |
48,509,044 |
RGD:6480464 |
CTD |
| G |
TRIB1 |
tribbles homolog 1 (Drosophila) |
|
increases expression |
ISO |
8 |
126,442,563 |
126,450,645 |
RGD:6480464 |
CTD |
| G |
TRIB3 |
tribbles homolog 3 (Drosophila) |
|
increases expression |
ISO |
20 |
361,308 |
378,203 |
RGD:6480464 |
CTD |
| G |
TRIM16 |
tripartite motif containing 16 |
|
increases expression |
ISO |
17 |
15,531,280 |
15,586,193 |
RGD:6480464 |
CTD |
| G |
TSC22D3 |
TSC22 domain family, member 3 |
|
increases expression |
ISO |
X |
106,956,451 |
107,019,017 |
RGD:6480464 |
CTD |
| G |
TSR2 |
TSR2, 20S rRNA accumulation, homolog (S. cerevisiae) |
|
decreases expression |
ISO |
X |
54,466,853 |
54,471,730 |
RGD:6480464 |
CTD |
| G |
TTC13 |
tetratricopeptide repeat domain 13 |
|
decreases expression |
ISO |
1 |
231,041,987 |
231,114,618 |
RGD:6480464 |
CTD |
| G |
TTC30B |
tetratricopeptide repeat domain 30B |
|
decreases expression |
ISO |
2 |
178,414,880 |
178,417,524 |
RGD:6480464 |
CTD |
| G |
TTLL3 |
tubulin tyrosine ligase-like family, member 3 |
|
increases expression |
ISO |
3 |
9,851,644 |
9,878,040 |
RGD:6480464 |
CTD |
| G |
TXNIP |
thioredoxin interacting protein |
|
decreases expression |
ISO |
1 |
145,438,462 |
145,442,635 |
RGD:6480464 |
CTD |
| G |
TXNRD1 |
thioredoxin reductase 1 |
|
increases expression |
EXP |
12 |
104,609,557 |
104,744,085 |
RGD:6480464 |
CTD |
| G |
TYMS |
thymidylate synthetase |
|
decreases expression |
ISO |
18 |
657,604 |
673,499 |
RGD:6480464 |
CTD |
| G |
UBC |
ubiquitin C |
|
increases expression |
ISO |
12 |
125,396,192 |
125,399,587 |
RGD:6480464 |
CTD |
| G |
UBR3 |
ubiquitin protein ligase E3 component n-recognin 3 (putative) |
|
decreases expression |
ISO |
2 |
170,684,018 |
170,940,641 |
RGD:6480464 |
CTD |
| G |
UCHL3 |
ubiquitin carboxyl-terminal esterase L3 (ubiquitin thiolesterase) |
|
decreases expression |
ISO |
13 |
76,123,616 |
76,180,156 |
RGD:6480464 |
CTD |
| G |
ULK2 |
unc-51-like kinase 2 (C. elegans) |
|
decreases expression |
ISO |
17 |
19,674,143 |
19,771,239 |
RGD:6480464 |
CTD |
| G |
USP12 |
ubiquitin specific peptidase 12 |
|
decreases expression |
ISO |
13 |
27,640,287 |
27,746,033 |
RGD:6480464 |
CTD |
| G |
VAMP4 |
vesicle-associated membrane protein 4 |
|
decreases expression |
ISO |
1 |
171,669,296 |
171,711,379 |
RGD:6480464 |
CTD |
| G |
VEGFA |
vascular endothelial growth factor A |
|
increases secretion |
ISO |
6 |
43,737,946 |
43,754,224 |
RGD:6480464 |
CTD |
| G |
VPS54 |
vacuolar protein sorting 54 homolog (S. cerevisiae) |
|
decreases expression |
ISO |
2 |
64,119,667 |
64,246,214 |
RGD:6480464 |
CTD |
| G |
WDR77 |
WD repeat domain 77 |
|
decreases expression |
ISO |
1 |
111,982,512 |
111,991,830 |
RGD:6480464 |
CTD |
| G |
WEE1 |
WEE1 homolog (S. pombe) |
|
decreases expression |
ISO |
11 |
9,595,228 |
9,611,314 |
RGD:6480464 |
CTD |
| G |
WNT2 |
wingless-type MMTV integration site family member 2 |
|
increases expression |
EXP |
7 |
116,916,685 |
116,963,343 |
RGD:6480464 |
CTD |
| G |
WSB1 |
WD repeat and SOCS box containing 1 |
|
increases expression |
ISO |
17 |
25,621,106 |
25,640,645 |
RGD:6480464 |
CTD |
| G |
WWC1 |
WW and C2 domain containing 1 |
|
increases expression |
ISO |
5 |
167,719,065 |
167,899,308 |
RGD:6480464 |
CTD |
| G |
XBP1 |
X-box binding protein 1 |
|
increases splicing |
EXP |
22 |
29,190,548 |
29,196,560 |
RGD:6480464 |
CTD |
| G |
XBP1 |
X-box binding protein 1 |
|
multiple interactions |
EXP |
22 |
29,190,548 |
29,196,560 |
RGD:6480464 |
CTD |
| G |
XCR1 |
chemokine (C motif) receptor 1 |
|
decreases expression |
EXP |
3 |
46,062,291 |
46,068,979 |
RGD:6480464 |
CTD |
| G |
XDH |
xanthine dehydrogenase |
|
increases expression |
ISO |
2 |
31,557,188 |
31,637,611 |
RGD:6480464 |
CTD |
| G |
ZADH2 |
zinc binding alcohol dehydrogenase domain containing 2 |
|
decreases expression |
ISO |
18 |
72,909,278 |
72,921,281 |
RGD:6480464 |
CTD |
| G |
ZBTB1 |
zinc finger and BTB domain containing 1 |
|
decreases expression |
ISO |
14 |
64,971,292 |
65,000,408 |
RGD:6480464 |
CTD |
| G |
ZBTB12 |
zinc finger and BTB domain containing 12 |
|
decreases expression |
ISO |
6 |
31,867,394 |
31,869,769 |
RGD:6480464 |
CTD |
| G |
ZBTB14 |
zinc finger and BTB domain containing 14 |
|
decreases expression |
ISO |
18 |
5,289,018 |
5,297,052 |
RGD:6480464 |
CTD |
| G |
ZBTB18 |
zinc finger and BTB domain containing 18 |
|
decreases expression |
ISO |
1 |
244,214,561 |
244,220,778 |
RGD:6480464 |
CTD |
| G |
ZBTB21 |
zinc finger and BTB domain containing 21 |
|
increases expression |
ISO |
21 |
43,406,940 |
43,430,496 |
RGD:6480464 |
CTD |
| G |
ZBTB45 |
zinc finger and BTB domain containing 45 |
|
decreases expression |
ISO |
19 |
59,024,897 |
59,030,921 |
RGD:6480464 |
CTD |
| G |
ZC3H11A |
zinc finger CCCH-type containing 11A |
|
increases expression |
ISO |
1 |
203,764,751 |
203,823,256 |
RGD:6480464 |
CTD |
| G |
ZC3H12A |
zinc finger CCCH-type containing 12A |
|
increases expression |
ISO |
1 |
37,940,119 |
37,949,978 |
RGD:6480464 |
CTD |
| G |
ZC3H14 |
zinc finger CCCH-type containing 14 |
|
decreases expression |
ISO |
14 |
89,029,253 |
89,079,853 |
RGD:6480464 |
CTD |
| G |
ZDHHC2 |
zinc finger, DHHC-type containing 2 |
|
decreases expression |
ISO |
8 |
17,013,836 |
17,080,241 |
RGD:6480464 |
CTD |
| G |
ZFAND2A |
zinc finger, AN1-type domain 2A |
|
increases expression |
ISO |
7 |
1,192,543 |
1,199,855 |
RGD:6480464 |
CTD |
| G |
ZFAND5 |
zinc finger, AN1-type domain 5 |
|
increases expression |
ISO |
9 |
74,966,341 |
74,980,163 |
RGD:6480464 |
CTD |
| G |
ZFHX4 |
zinc finger homeobox 4 |
|
decreases expression |
ISO |
8 |
77,593,515 |
77,779,521 |
RGD:6480464 |
CTD |
| G |
ZFP36 |
ZFP36 ring finger protein |
|
increases expression |
ISO |
19 |
39,897,487 |
39,900,052 |
RGD:6480464 |
CTD |
| G |
ZFYVE21 |
zinc finger, FYVE domain containing 21 |
|
decreases expression |
ISO |
14 |
104,182,081 |
104,200,005 |
RGD:6480464 |
CTD |
| G |
ZIK1 |
zinc finger protein interacting with K protein 1 |
|
decreases expression |
ISO |
19 |
58,095,628 |
58,103,758 |
RGD:6480464 |
CTD |
| G |
ZMAT3 |
zinc finger, matrin-type 3 |
|
decreases expression |
ISO |
3 |
178,735,011 |
178,789,656 |
RGD:6480464 |
CTD |
| G |
ZNF148 |
zinc finger protein 148 |
|
decreases expression |
ISO |
3 |
124,944,513 |
125,094,198 |
RGD:6480464 |
CTD |
| G |
ZNF207 |
zinc finger protein 207 |
|
decreases expression |
ISO |
17 |
30,677,157 |
30,697,468 |
RGD:6480464 |
CTD |
| G |
ZNF362 |
zinc finger protein 362 |
|
decreases expression |
ISO |
1 |
33,722,174 |
33,766,320 |
RGD:6480464 |
CTD |
| G |
ZNF519 |
zinc finger protein 519 |
|
decreases expression |
ISO |
18 |
14,075,989 |
14,132,489 |
RGD:6480464 |
CTD |
| G |
ZNF571 |
zinc finger protein 571 |
|
decreases expression |
ISO |
19 |
38,055,155 |
38,085,673 |
RGD:6480464 |
CTD |
| G |
ZNF654 |
zinc finger protein 654 |
|
decreases expression |
ISO |
3 |
88,188,262 |
88,193,814 |
RGD:6480464 |
CTD |
| G |
ZNF703 |
zinc finger protein 703 |
|
increases expression |
ISO |
8 |
37,553,301 |
37,556,396 |
RGD:6480464 |
CTD |
| G |
ZNF878 |
zinc finger protein 878 |
|
decreases expression |
ISO |
19 |
12,154,620 |
12,163,782 |
RGD:6480464 |
CTD |
| G |
ZNFX1 |
zinc finger, NFX1-type containing 1 |
|
decreases expression |
ISO |
20 |
47,862,437 |
47,894,756 |
RGD:6480464 |
CTD |
| G |
ZNRF2 |
zinc and ring finger 2 |
|
decreases expression |
ISO |
7 |
30,323,923 |
30,407,308 |
RGD:6480464 |
CTD |
| G |
ZYG11B |
zyg-11 family member B, cell cycle regulator |
|
decreases expression |
ISO |
1 |
53,192,131 |
53,293,014 |
RGD:6480464 |
CTD |
quartz
|
| G |
ANXA5 |
annexin A5 |
|
increases expression |
ISO |
4 |
122,589,152 |
122,618,147 |
RGD:6480464 |
CTD |
| G |
ARG1 |
arginase, liver |
|
increases expression |
ISO |
6 |
131,894,344 |
131,905,472 |
RGD:6480464 |
CTD |
| G |
ATP1B1 |
ATPase, Na+/K+ transporting, beta 1 polypeptide |
|
affects expression |
ISO |
1 |
169,075,947 |
169,101,960 |
RGD:6480464 |
CTD |
| G |
ATP6V1B2 |
ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2 |
|
affects expression |
ISO |
8 |
20,054,704 |
20,079,207 |
RGD:6480464 |
CTD |
| G |
C2CD4B |
C2 calcium-dependent domain containing 4B |
|
increases expression |
ISO |
15 |
62,455,737 |
62,457,482 |
RGD:6480464 |
CTD |
| G |
C4BPA |
complement component 4 binding protein, alpha |
|
increases expression |
ISO |
1 |
207,277,607 |
207,318,317 |
RGD:6480464 |
CTD |
| G |
CAPG |
capping protein (actin filament), gelsolin-like |
|
affects expression |
ISO |
2 |
85,621,871 |
85,641,197 |
RGD:6480464 |
CTD |
| G |
CAT |
catalase |
|
multiple interactions |
ISO |
11 |
34,460,472 |
34,493,607 |
RGD:6480464 |
CTD |
| G |
CCL17 |
chemokine (C-C motif) ligand 17 |
|
increases expression |
ISO |
16 |
57,438,679 |
57,449,974 |
RGD:6480464 |
CTD |
| G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
ISO |
17 |
32,582,296 |
32,584,222 |
RGD:6480464 |
CTD |
| G |
CCL3 |
chemokine (C-C motif) ligand 3 |
|
increases expression |
ISO |
17 |
34,415,602 |
34,417,506 |
RGD:6480464 |
CTD |
| G |
CCL7 |
chemokine (C-C motif) ligand 7 |
|
increases expression |
ISO |
17 |
32,597,240 |
32,599,256 |
RGD:6480464 |
CTD |
| G |
CCNA2 |
cyclin A2 |
|
increases expression |
ISO |
4 |
122,737,599 |
122,745,088 |
RGD:6480464 |
CTD |
| G |
CFI |
complement factor I |
|
increases expression |
ISO |
4 |
110,661,848 |
110,723,335 |
RGD:6480464 |
CTD |
| G |
CH25H |
cholesterol 25-hydroxylase |
|
increases expression |
ISO |
10 |
90,965,694 |
90,967,071 |
RGD:6480464 |
CTD |
| G |
CHIA |
chitinase, acidic |
|
increases expression |
ISO |
1 |
111,833,474 |
111,863,188 |
RGD:6480464 |
CTD |
| G |
CPB2 |
carboxypeptidase B2 (plasma) |
|
increases expression |
ISO |
13 |
46,627,322 |
46,679,211 |
RGD:6480464 |
CTD |
| G |
CTSK |
cathepsin K |
|
increases expression |
ISO |
1 |
150,768,684 |
150,780,917 |
RGD:6480464 |
CTD |
| G |
CXCL1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
increases expression |
ISO |
4 |
74,735,109 |
74,737,019 |
RGD:6480464 |
CTD |
| G |
CXCL2 |
chemokine (C-X-C motif) ligand 2 |
|
multiple interactions |
ISO |
4 |
74,962,752 |
74,964,997 |
RGD:6480464 |
CTD |
| G |
CXCL2 |
chemokine (C-X-C motif) ligand 2 |
|
increases expression |
ISO |
4 |
74,962,752 |
74,964,997 |
RGD:6480464 |
CTD |
| G |
CXCL5 |
chemokine (C-X-C motif) ligand 5 |
|
increases expression |
ISO |
4 |
74,861,359 |
74,864,416 |
RGD:6480464 |
CTD |
| G |
CYP2E1 |
cytochrome P450, family 2, subfamily E, polypeptide 1 |
|
decreases expression |
ISO |
10 |
135,340,867 |
135,352,620 |
RGD:6480464 |
CTD |
| G |
FABP4 |
fatty acid binding protein 4, adipocyte |
|
increases expression |
ISO |
8 |
82,390,732 |
82,395,473 |
RGD:6480464 |
CTD |
| G |
FCGR2B |
Fc fragment of IgG, low affinity IIb, receptor (CD32) |
|
increases expression |
ISO |
1 |
161,632,905 |
161,648,444 |
RGD:6480464 |
CTD |
| G |
FGG |
fibrinogen gamma chain |
|
increases expression |
ISO |
4 |
155,525,286 |
155,533,902 |
RGD:6480464 |
CTD |
| G |
G6PD |
glucose-6-phosphate dehydrogenase |
|
multiple interactions |
ISO |
X |
153,759,606 |
153,775,787 |
RGD:6480464 |
CTD |
| G |
G6PD |
glucose-6-phosphate dehydrogenase |
|
decreases activity |
ISO |
X |
153,759,606 |
153,775,787 |
RGD:6480464 |
CTD |
| G |
HAPLN4 |
hyaluronan and proteoglycan link protein 4 |
|
affects expression |
ISO |
19 |
19,366,450 |
19,373,596 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HP |
haptoglobin |
|
increases expression |
ISO |
16 |
72,088,508 |
72,094,955 |
RGD:6480464 |
CTD |
| G |
IFNG |
interferon, gamma |
|
multiple interactions |
ISO |
12 |
68,548,550 |
68,553,521 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
increases secretion |
EXP |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1R2 |
interleukin 1 receptor, type II |
|
increases expression |
ISO |
2 |
102,608,306 |
102,644,885 |
RGD:6480464 |
CTD |
| G |
ITGAM |
integrin, alpha M (complement component 3 receptor 3 subunit) |
|
increases expression |
ISO |
16 |
31,271,288 |
31,344,213 |
RGD:6480464 |
CTD |
| G |
ITIH1 |
inter-alpha-trypsin inhibitor heavy chain 1 |
|
increases expression |
ISO |
3 |
52,811,602 |
52,826,084 |
RGD:6480464 |
CTD |
| G |
LCN2 |
lipocalin 2 |
|
increases expression |
ISO |
9 |
130,911,732 |
130,915,734 |
RGD:6480464 |
CTD |
| G |
MAL2 |
mal, T-cell differentiation protein 2 (gene/pseudogene) |
|
affects expression |
ISO |
8 |
120,220,610 |
120,257,913 |
RGD:6480464 |
CTD |
| G |
MIR138-1 |
microRNA 138-1 |
|
increases expression |
ISO |
3 |
44,155,704 |
44,155,802 |
RGD:6480464 |
CTD |
| G |
MIR140 |
microRNA 140 |
|
decreases expression |
ISO |
16 |
69,966,984 |
69,967,083 |
RGD:6480464 |
CTD |
| G |
MIR141 |
microRNA 141 |
|
increases expression |
ISO |
12 |
7,073,260 |
7,073,354 |
RGD:6480464 |
CTD |
| G |
MIR144 |
microRNA 144 |
|
decreases expression |
ISO |
17 |
27,188,551 |
27,188,636 |
RGD:6480464 |
CTD |
| G |
MIR145 |
microRNA 145 |
|
decreases expression |
ISO |
5 |
148,810,209 |
148,810,296 |
RGD:6480464 |
CTD |
| G |
MIR146A |
microRNA 146a |
|
increases expression |
ISO |
5 |
159,912,359 |
159,912,457 |
RGD:6480464 |
CTD |
| G |
MIR146B |
microRNA 146b |
|
increases expression |
ISO |
10 |
104,196,269 |
104,196,341 |
RGD:6480464 |
CTD |
| G |
MIR182 |
microRNA 182 |
|
increases expression |
ISO |
7 |
129,410,223 |
129,410,332 |
RGD:6480464 |
CTD |
| G |
MIR183 |
microRNA 183 |
|
increases expression |
ISO |
7 |
129,414,745 |
129,414,854 |
RGD:6480464 |
CTD |
| G |
MIR200B |
microRNA 200b |
|
decreases expression |
ISO |
1 |
1,102,484 |
1,102,578 |
RGD:6480464 |
CTD |
| G |
MIR204 |
microRNA 204 |
|
increases expression |
ISO |
9 |
73,424,891 |
73,425,000 |
RGD:6480464 |
CTD |
| G |
MIR22 |
microRNA 22 |
|
increases expression |
ISO |
17 |
1,617,197 |
1,617,281 |
RGD:6480464 |
CTD |
| G |
MIR25 |
microRNA 25 |
|
decreases expression |
ISO |
7 |
99,691,183 |
99,691,266 |
RGD:6480464 |
CTD |
| G |
MIR26B |
microRNA 26b |
|
decreases expression |
ISO |
2 |
219,267,369 |
219,267,445 |
RGD:6480464 |
CTD |
| G |
MIR28 |
microRNA 28 |
|
decreases expression |
ISO |
3 |
188,406,569 |
188,406,654 |
RGD:6480464 |
CTD |
| G |
MIR299 |
microRNA 299 |
|
increases expression |
ISO |
14 |
101,490,131 |
101,490,193 |
RGD:6480464 |
CTD |
| G |
MIR29C |
microRNA 29c |
|
decreases expression |
ISO |
1 |
207,975,197 |
207,975,284 |
RGD:6480464 |
CTD |
| G |
MIR300 |
microRNA 300 |
|
increases expression |
ISO |
14 |
101,507,700 |
101,507,782 |
RGD:6480464 |
CTD |
| G |
MIR30A |
microRNA 30a |
|
decreases expression |
ISO |
6 |
72,113,254 |
72,113,324 |
RGD:6480464 |
CTD |
| G |
MIR30D |
microRNA 30d |
|
decreases expression |
ISO |
8 |
135,817,119 |
135,817,188 |
RGD:6480464 |
CTD |
| G |
MIR30E |
microRNA 30e |
|
decreases expression |
ISO |
1 |
41,220,027 |
41,220,118 |
RGD:6480464 |
CTD |
| G |
MIR345 |
microRNA 345 |
|
decreases expression |
ISO |
14 |
100,774,196 |
100,774,293 |
RGD:6480464 |
CTD |
| G |
MIR375 |
microRNA 375 |
|
decreases expression |
ISO |
2 |
219,866,367 |
219,866,430 |
RGD:6480464 |
CTD |
| G |
MIR505 |
microRNA 505 |
|
decreases expression |
ISO |
X |
139,006,307 |
139,006,390 |
RGD:6480464 |
CTD |
| G |
MIR96 |
microRNA 96 |
|
increases expression |
ISO |
7 |
129,414,532 |
129,414,609 |
RGD:6480464 |
CTD |
| G |
MIR98 |
microRNA 98 |
|
decreases expression |
ISO |
X |
53,583,184 |
53,583,302 |
RGD:6480464 |
CTD |
| G |
MIR99A |
microRNA 99a |
|
decreases expression |
ISO |
21 |
17,911,409 |
17,911,489 |
RGD:6480464 |
CTD |
| G |
MIRLET7D |
microRNA let-7d |
|
decreases expression |
ISO |
9 |
96,941,116 |
96,941,202 |
RGD:6480464 |
CTD |
| G |
MMP12 |
matrix metallopeptidase 12 (macrophage elastase) |
|
increases expression |
ISO |
11 |
102,733,464 |
102,745,764 |
RGD:6480464 |
CTD |
| G |
MSR1 |
macrophage scavenger receptor 1 |
|
increases expression |
ISO |
8 |
15,965,387 |
16,050,300 |
RGD:6480464 |
CTD |
| G |
NOXO1 |
NADPH oxidase organizer 1 |
|
increases expression |
ISO |
16 |
2,028,918 |
2,031,550 |
RGD:6480464 |
CTD |
| G |
PLAUR |
plasminogen activator, urokinase receptor |
|
affects expression |
ISO |
19 |
44,150,247 |
44,174,498 |
RGD:6480464 |
CTD |
| G |
PRDX5 |
peroxiredoxin 5 |
|
affects expression |
ISO |
11 |
64,085,560 |
64,089,295 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
increases expression |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
increases expression |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
increases expression |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
S100A9 |
S100 calcium binding protein A9 |
|
increases expression |
ISO |
1 |
153,330,330 |
153,333,503 |
RGD:6480464 |
CTD |
| G |
SDF2L1 |
stromal cell-derived factor 2-like 1 |
|
affects expression |
ISO |
22 |
21,996,542 |
21,998,588 |
RGD:6480464 |
CTD |
| G |
SERPINA10 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10 |
|
increases expression |
ISO |
14 |
94,749,650 |
94,759,596 |
RGD:6480464 |
CTD |
| G |
SLC26A4 |
solute carrier family 26, member 4 |
|
increases expression |
ISO |
7 |
107,301,080 |
107,358,254 |
RGD:6480464 |
CTD |
| G |
SOD2 |
superoxide dismutase 2, mitochondrial |
|
increases expression |
ISO |
6 |
160,100,148 |
160,114,353 |
RGD:6480464 |
CTD |
| G |
SPP1 |
secreted phosphoprotein 1 |
|
increases expression |
ISO |
4 |
88,896,802 |
88,904,563 |
RGD:6480464 |
CTD |
| G |
TFRC |
transferrin receptor (p90, CD71) |
|
increases expression |
ISO |
3 |
195,776,155 |
195,809,032 |
RGD:6480464 |
CTD |
| G |
TGFBR1 |
transforming growth factor, beta receptor 1 |
|
increases expression |
ISO |
9 |
101,867,412 |
101,916,474 |
RGD:6480464 |
CTD |
| G |
TIAM1 |
T-cell lymphoma invasion and metastasis 1 |
|
increases expression |
ISO |
21 |
32,490,736 |
32,931,290 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
increases expression |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
increases secretion |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
increases activity |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
increases expression |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
increases secretion |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
increases expression |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
increases secretion |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
increases secretion |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
increases secretion |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
increases expression |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
increases expression |
ISO |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
increases mutagenesis |
ISO |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TREM2 |
triggering receptor expressed on myeloid cells 2 |
|
increases expression |
ISO |
6 |
41,126,246 |
41,130,922 |
RGD:6480464 |
CTD |
Term paths to the root
|